                         SEQUENCE LISTING

<110>  VANDERBILT UNIVERSITY
 
<120>  HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME 
       CORONAVIRUS 2 (SARS-COV- 2)

<130>  VBLT.P0307WO7

<150>  US 63/000,735
<151>  2020-03-27

<150>  US 63/024,214
<151>  2020-05-13

<150>  US 63/023,545
<151>  2020-05-12

<150>  US 63/002,896
<151>  2020-03-31

<150>  US 63/024,248
<151>  2020-05-13

<150>  US 63/027,173
<151>  2020-05-19

<150>  US 63/037,984
<151>  2020-06-11

<150>  US 63/040,246
<151>  2020-06-17

<150>  US 63/142,196
<151>  2021-01-27

<160>  1073  

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  1
atgctgcaat cgtgctacaa                                                   20


<210>  2
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic primer

<400>  2
gactgccgcc tctgctc                                                      17


<210>  3
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  3
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgtag cctctggatt cacctttagt ttctattgga tgagctgggt ccgccaggct      120

ccaggaaagg ggctcgagtg ggtggccaac ataaagcaag atggaggtga gaaatactat      180

gtggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagactgtct      300

ggcagcagct gggactttga ctactggggc cagggaaccc tggtcaccgt ctcctca         357


<210>  4
<211>  318
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  4
tcctatgagc tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggggataaa tatgcttgtt ggtaccaaca gaggccaggc      120

cagtcccctg tgctggtcat ctatcaagat agtaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg gacagcagca ctggagtctt cggaactggg      300

accaaggtca ccgtccta                                                    318


<210>  5
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  5
gaggtgcagc tggtggagtc tgggggaggt gtggtacggc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatggca tgagctgggt ccgccaagct      120

ccagggaagg ggctggagtg ggtctctgct attaattgga atggtggtag cacaggttat      180

gcagactctg taaagggccg attcaccatc tccagagata atgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agccgaggac acggccttgt atcactgtgc gagacggcgt      300

agctcgtccc ggtatagcag tggctggtat atgtactact actacatgga cgtctggggc      360

aaagggacca cggtcaccgt ctcctca                                          387


<210>  6
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  6
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtgttagt acctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaacctcct gatctatgag gcgtctagtt tagaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacttatta ctgccaacag tataatactt attcggggac gttcggccaa      300

gggaccaagg tggaaatcaa a                                                321


<210>  7
<211>  360
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  7
cagatcacct tcaaggagtc tggtcctacg ctggtgaaac ccacagagac cctcacgctg       60

acctgcacct tctctgggtt ctcagtcagc actagtggag agggtgtggg ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gcagtcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaggg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcacacagg      300

ctttggttca gggatgcttt tgatatttgg ggccaaggga caacggtcac cgtctcctca      360


<210>  8
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  8
gacatccaga tgacccagtc tccatcgtcc ctgtctgcat ctgtaggaga cagagtcaca       60

atcacttgcc gggcacgtca gagcattagc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcacagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag acttacagta ccttctggac gttcggccaa      300

gggaccaacg tggaaatcaa a                                                321


<210>  9
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  9
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctaagactc       60

tcctgtgcag cctctggatt cacctttagt acctattgga tgacctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaagcaag atggaagtga gaaatactat      180

gtggactctg ttaagtaccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagagtcggg      300

agcagcagct ggtactttga ctactggggc cagggaaccc tggtcaccgt ctcctca         357


<210>  10
<211>  318
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  10
tcctatgaac tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggggataaa tatgcttgct ggtatcagca gaagccaggc      120

cagtcccctg tggtggtcat ctatcaagat agcaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg gacagcagca ctgcggtatt cggcggaggg      300

accaagctga ccgtccta                                                    318


<210>  11
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  11
cagctacagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtggaactt actactgcgg ctggatccgc      120

cagcccccag ggaaggggct ggagtggatt gggagtacat attatggtgg gagcaccctc      180

tacaacccgt ccctcagggg tcgagtcacc atatccgtag acacgtccaa gaaccagttt      240

tccctgaagc tgagctctgt gaccgccgca gacacggctg tgtattactg tgcgagacgg      300

ggtaattact atgatagtaa gaactggttc gacccctggg gccagggaac cctggtcacc      360

gtctcctca                                                              369


<210>  12
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  12
gaaatagtga tgacgcagtc tccagccacc gtgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg ccagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataataact ggccacctat gtacactttt      300

ggccagggga ccaaggtgga gatcaaa                                          327


<210>  13
<211>  360
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  13
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagagtc       60

tcctgtgcag cgtctggatt caccttcagt agccatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtgtcagtt atatggtatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtct      240

ctgcaaatga acagcctgag agccgaagac acggctgtgt attactgtgc gagagagagc      300

gcggacatat catctcgtct tgactactgg ggccggggaa ccctggtcac cgtctcctca      360


<210>  14
<211>  318
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  14
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacaaac ggccaggatc       60

acctgctctg gagatgcatt gccaacaaaa tatgcttatt ggtaccagca gaagtcaggc      120

caggcccctg tgctggtcat ctatgacgac agcaaacgac cctccgggat ccctgagaga      180

ttctctggct ccagctcagg gacaatggcc accttgacta tcagtggggc ccaggtggag      240

gatgaagctg actactactg ttactcaaca gacagcagtg gtaatgtctt cggaactggg      300

accaaggtca ccgtccta                                                    318


<210>  15
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  15
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcaggt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagcggac      300

actatggttc ggggaactta ttttgagtac tggggccagg gaaccctggt caccgtctcc      360

tca                                                                    363


<210>  16
<211>  330
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  16
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataact atgtctcttg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattgctgc agctcatata caagcagcag agctgtgcta      300

ttcggcggag ggaccaagct gaccgtccta                                       330


<210>  17
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  17
cagatcacct tgaaggagtc tggtcctacg ctggtaaaac ccacacagac cctcacgctg       60

acctgcacct tctctgggtt ctcactcagc actagtggag tgggtgtggc ctggatccgt      120

cagcccccag gaaaggccct ggagtggctt gctctcattt attgggatga tgataagcgc      180

tacagcccat ctctgaagag caggctcacc atcaccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca catattactg tgcacacaga      300

cttccaacgc cccaactgct accatctttt gaaaactggt tcgacccctg gggccaggga      360

accctggtca ccgtctcctc a                                                381


<210>  18
<211>  330
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  18
cagtctgtgc tgactcagcc accctcggtg tctgaagccc ccaggcagag ggtcaccatc       60

tcctgttctg gaggcagctc caacatcgga aataatgctg taaactggta ccagcagctc      120

ccaggaaagg ctcccaaact cctcatctat tatgatgatc tgctgccctc aggggtctct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaagatg aggctgatta ttactgtgca tcatgggatg acagcctgat tggtccggta      300

ttcggcggag ggaccaagct gaccgtccta                                       330


<210>  19
<211>  360
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  19
gaggtgcagc tggtggagtc cgggggaggc ttagttcagc ctggggggtc cctgagactc       60

tcctgtgcag tctctggatt caccttcagt agctactgga tgcactgggt ccgccaagct      120

ccagggaagg ggctggtgtg ggtctcacgt attaatagtg atgggagtag cacaagctac      180

gcggactccg tgaagggccg attcaccatc tccagagaca acgccaagaa cacgctgtat      240

ctgcaaatga acagtctgag agccgaggac acggctgtgt attactgtgc aagagaagtg      300

gagcagctgg ctcatatggt tgactactgg ggccagggaa ccctggtcac cgtctcctca      360


<210>  20
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  20
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaaccaa tatgcttatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcagca gacagcagtg gtacatcttg ggtgttcggc      300

ggagggacca agctgaccgt ccta                                             324


<210>  21
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  21
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaatcaa taaatactac      180

gcagacgccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaggccacga      300

agtgggagct actacgccta ctttgactac tggggccagg gaaccctggt caccgtctcc      360

tca                                                                    363


<210>  22
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  22
gacatccaga tgacccagtc tccatcctca ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgtc gggcgagtca gggcattagc aattatttag cctggtttca gcagaaacca      120

gggaaagccc ctaagtccct gatctatgct gcatccagtt tacaaagtgg ggtcccatca      180

aagttcagcg gcagtggatc tgggacagat ttcactctca ccatcagcag cctgcagcct      240

gaagatgttg caacttatta ctgccaacag tataatagtc accctcccac tttcggcgga      300

gggaccaagg tggagatcaa a                                                321


<210>  23
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  23
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt tactatccta tgcactggct ctgggtccgc      120

caggctccag gcaaggggct ggagtgggtg gcagttacat catatgatgg aaccaataaa      180

tactacgcag actccgtgaa gggccgattc accatctcca gagacaattc caagaacact      240

ctgtatctgc aaatgaacag cctgagagct gaggacacgg ctgtgtatta ctgtgcgaga      300

gggggagcta ctaactttga ctactggggc cagggaaccc tggtcaccgt ctcctca         357


<210>  24
<211>  330
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  24
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaacatt       60

acctgtgggg gaaacaacat tggaagaaaa agtgtgcact ggtaccagca gaagtcaggc      120

caggcccctg tgctggtcgt ctatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actattactg tcaggtgtgg gatagtagta gtgatcatcc ggagtgggtg      300

ttcggcggag ggaccaagct gaccgtccta                                       330


<210>  25
<211>  378
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  25
gaagcgcagc tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattctgcca tgcactgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagttgga atagtggtaa cgtaggctat      180

gcggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agctgaggac acggccttgt attactgtac aaaagcctct      300

cgatattgta gtagtaccat ctgctattgg aactggttcg acccctgggg ccagggaacc      360

ctggtcaccg tctcctca                                                    378


<210>  26
<211>  318
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  26
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatggt gcatccagtt tgcaaactgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagaag tctgcaacct      240

gaagattttg caagttacta ctgtcaacag agttacagta cccccacttt cggcggaggg      300

accaaggtgg agatcaaa                                                    318


<210>  27
<211>  378
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  27
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggagggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agttatgaaa tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtttcatac attagtagta gtggtagtgc catatactac      180

gcagactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agtcgaggac acggctgttt attactgtgc gagagaagcg      300

cggtcacgat attttgactg gttaccctcg tactactttg actactgggg ccagggaacc      360

ctggtcaccg tctcctca                                                    378


<210>  28
<211>  333
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  28
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacattggt ggttataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcctgatt tatgatgtca gtaatcggcc ctcaggggtt      180

tctactcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata caagcagcag cacccatgtg      300

gtgttcggcg gagggaccaa gctgaccgtc cta                                   333


<210>  29
<211>  374
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  29
caggtgcagc tggtgcaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcact acctatgcta tgaattgggt gcgacaggcc      120

cctggacaag gacttgagtg gatgggatgg atcaacacca acactgggaa cccaacgtat      180

gcccagggct tcacaggacg gtttgtcttc tccttggaca cctctgtcaa cacggcattt      240

ctgcatatcg gcagcctaaa ggctgaggac actgccgtgt attactgtgc gagagatcag      300

gacagtggct acccaactta ctactactac tacatggacg tctggggcaa agggaccacg      360

gtcaccgtct cctc                                                        374


<210>  30
<211>  336
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  30
gatattgtga tgacccagac tccactctct ctgtccgtca cccctggaca gccggcctcc       60

atctcctgca agtctagtca gagcctcctg catagtgatg gaaagaccta tttgtattgg      120

tacctgcaga agccaggcca gtctccacag ctcctgatct atgaagtttc caaccggttc      180

tctggagtgc cagataggtt cagtggcagc gggtcaggga cagatttcac actgaaaatc      240

agccgggtgg aggctgagga tgttggggtt tattactgca tgcaaagtat acagcctcct      300

ctcactttcg gcggagggac caaggtggag atcaaa                                336


<210>  31
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  31
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggcgtg ggtggcactt atatcatatg atggatataa taaatactac      180

gcagactccg tgaggggccg attcaccatc tccagaatca attccaagaa cacgctgtct      240

ctgcagatga acagcctgag agctgaggac acggctgtct attactgtgc gagagggtca      300

gctggaaact actactacgg tatggacgtc tggggccagg ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  32
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  32
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gaccattacc aactatttaa attggtatca gctgaaatca      120

gggagagccc ccaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta cgccgtacac ttttggccag      300

gggaccaagc tggagatcaa a                                                321


<210>  33
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  33
caggtgcatc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt aactatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atctcaaatg atgaatttaa taaattctat      180

gcaaactccg tgaagggccg attcaccatc tccagagaca attcgaagaa cacggtgtat      240

ttgcaattga acagtctgag aactgaggac acggctcgat attactgtgc gaaagggggg      300

gatggcagtg gctgggcctg ggacggtgat aaccccccaa cggactactg gggccaggga      360

accctggtca tcgtctcttc a                                                381


<210>  34
<211>  338
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  34
gacatcgtga tgacccagtc tccggacttc ctggctgtgt ctctgggcga gagggccacc       60

atcagctgca agtccagtca gagtgtttta tacaccccca agaataagaa ctacttagct      120

tggtacaagc agaaaccagg acagcctcct aaggtgctca tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcatc      240

atcagcagcc tgcaggctga ggatgcggca gtttattact gtcagcaata ttatactgct      300

cctctcactt tcggcggtgg gaccagggtg gagatcaa                              338


<210>  35

<400>  35
000

<210>  36

<400>  36
000

<210>  37
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  37
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc agctactgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg gtgactctga taccagatac      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccatcag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagacccgac      300

tatagcagtg gctggtttag ctactggtac ttcgatctct ggggccgtgg caccctggtc      360

actgtctcct ca                                                          372


<210>  38
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  38
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttct tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgccag cagtatggtc gctcaccgat caccttcggc      300

caagggacac gactggagat taaa                                             324


<210>  39
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  39
caggtccagc tggtacagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg tttccggata caccctcact gaactatcca tacactgggt gcgacaggct      120

cctggaaaag ggcttgagtg gatgggaggt tttgatcctg aagatgctga aacaatctac      180

gcacagcagt tccagggcag agtcaccatg accgaggaca catctacaga cacagcctac      240

atggagctga gcagcctgaa atctgaggac acggccctgt attactgtgc aacagggttc      300

gcggtgtttg ggagggcagc agttccctac tggggccagg gaaccctggt caccgtctcc      360

tca                                                                    363


<210>  40
<211>  318
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  40
tcctatgagc tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctttg gagataaatt gggggataaa tatgcttgct ggtttcagca gaagccaggc      120

cagtcccctg tgctgatcat ctatcaaggt gccaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg gacagcagca ctgtggtttt cggcggaggg      300

accaagctga ccgtccta                                                    318


<210>  41
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  41
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt cacgttcagt agctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaaagatctc      300

acaattgtag taataccagc tgccccaaat tttgactact ggggccaggg aaccctggtc      360

accgtctcct ca                                                          372


<210>  42
<211>  333
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  42
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt ggttataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caggtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga ttattactgc agctcatata caagcagcag cactcctgtg      300

gtgttcggcg gagggaccaa gctgaccgtc cta                                   333


<210>  43
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  43
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc agtcactgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg gtgactctga taccagatat      180

agcccgtcct tccaagggca ggtcaccatc tcagccgaca agtccatcag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatgt attactgtgc gagtgccctc      300

agagagcgag gcgtacagct gtggtcagtt tggggccagg gaaccctggt caccgtctcc      360

tca                                                                    363


<210>  44
<211>  330
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  44
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtacactg gtaccagcag      120

cttccaggaa cagcccccaa actcctcatc tttattaact ccaatcggcc ctcaggggtc      180

cctgaccgct tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagcagcct gggtgccttg      300

ttcggcggag ggaccaagct gaccgtccta                                       330


<210>  45
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  45
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cactctttat      240

ctgcaaatga acagcctgag agttgaggac acggctgtgt attactgtgc gagagatcaa      300

gaatggttca gggagttatt cctttttgac tactggggcc agggaaccct ggtcaccgtc      360

tcctca                                                                 366


<210>  46
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  46
gacatccaga tgacccagtc tccatcttcc gtgtctgcat ctgtaggaga cagagtcacc       60

atcacttgtc gggcgagtca gggtattagc agctggttag cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgat gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagat ttcactctca ccatcagcag cctgcagcct      240

gaagattttg caacttacta ttgtcaacag gctaacagtt tccctccgac tttcggccct      300

gggaccaaag tggatatcaa a                                                321


<210>  47
<211>  353
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  47
caggtgcagc tggtggagtc cgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacactgtat      240

ctgcaaatga acagcctgag agctgaggac acggctatgt attactgtgc gaaagatggg      300

agtatagcag cagctgacta ctggggccag ggaaccctgg tcaccgtctc ctc             353


<210>  48
<211>  339
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  48
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtctta cacagctcca acaacaagga ctccttagtt      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tttactgggc atctagccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtact      300

ccttggacgt tcggccaagg gaccaaggtg gaaatcaaa                             339


<210>  49
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  49
gaggtgcagc tggtggagtc tgggggaggc ctggtcaagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agttatagca tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcatcc ataagtaata gtaatagttt catatactac      180

gcagactcaa tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gcgagttaac      300

ggcaactcaa actggaactt tgggtcttac tactactact acatggacgt ctggggcaaa      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  50
<211>  318
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  50
gaaattgtgt tgacacagtc tccagccatt ttgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagt agctacttag cctggtacca acagaagcct      120

ggccaggctc ccaggctcct catctatgat acatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ctatcagcag cctagagcct      240

gaagattttg cattttatta ctgtcagcag cgtggcaact ggtggacgtt cgcccaaggg      300

accaaggtgg aaatcaaa                                                    318


<210>  51
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  51
gaggtgcagc tggtggagtc tgggggaggc ctggtcaagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cactttcagt ggctatagca tgaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcatcc attagtagta gtagtagtta catatactac      180

gcagactcag tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag ggccgaggac acggctgtgt attactgtgc gagatggcta      300

cagttaagat cagactacta ttacttcggt atggacgtct ggggccaagg gaccacggtc      360

accgtctcct ca                                                          372


<210>  52
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  52
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc aacaacttag cctggtacca gcacaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctacagtct      240

gaagattttg cagtttattt ctgtcagcag tgttataact ggcctccgtg gacgttcggc      300

caagggacca aggtggaaat caaa                                             324


<210>  53
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  53
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagt agttactact ggagctggat ccggcagccc      120

ccagggaagg gactggagtg gattggttat atctattaca gtgggagcac caactacaac      180

ccctccctca agagtcgagt caccatatca gtagacatgt ccaagaacca gttctccctg      240

aagctgaggt ctgtgaccgc tgcggacacg gccgtgtatt actgtgcgag agccccgagg      300

gaaaggctcc aatgggggga gtactacttc gactactggg gccagggaac cctggtcacc      360

gtctcctca                                                              369


<210>  54
<211>  333
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  54
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgatgttggg agttataacc ttgtctcctg gtaccaacag      120

catgcaggca aagcccccaa actcatgatt tatgaggtca ttaagcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgacaat ctctgggctc      240

caggctgagg acgaggctga ttattactgc tgctcatatg cagttagtac cacttatgtt      300

atattcggcg gagggaccaa gctgaccgtc cta                                   333


<210>  55
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  55
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc aactcctgga tcggctgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atctatcctg gtgactctga taccagatac      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccatcag caccgcctac      240

ctgcagtgga gcagcctgaa ggcctcggac accgccatct attactgtgc gacacatcgt      300

tgtagtggtg gtttctgcta cttagcctac tggggccagg gaaccctggt caccgtctcc      360

tca                                                                    363


<210>  56
<211>  351
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  56
cagcctgtgc tgactcagcc accttctgca tcagcctccc tgggagcctc ggtcacactc       60

acctgcaccc tgagcagcgg ctacagtaat tataaagtgg actggtacca gcagagacca      120

gggaagggcc cccggtttgt gatgcgagtg ggcactggtg ggattgtggg atccaagggg      180

gatggcatcc ctgatcgctt ctcagtcttg ggctcaggcc tgaatcggta cctgaccatc      240

aagaacatcc aggaagagga tgagagtgac taccactgtg gggcagacca tggcagtggg      300

agcaacttcg tttttgtggt tttcggcgga gggaccaagc tgaccgtcct a               351


<210>  57
<211>  384
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  57
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt agctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatggtatg atggaagtaa aaaagactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagagatcaa      300

tctcagggcg cttatatttt gactggttat aggggctacg gtatggacgt ctggggccag      360

gggaccacgg tcaccgtctc ctca                                             384


<210>  58
<211>  336
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  58
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca gatctagtca gagcctcctg catagtaatg gatacaacta tttggattgg      120

tacttgcaga agccagggca gtctccacag ttcctgatct atttgggttc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcaggca cagattttat actgaaaatc      240

agcagagtgg aggctgagga tgttggggtt tattactgca tgcaagctct tcaaactcca      300

ttcactttcg gccctgggac caaagtggat atcaaa                                336


<210>  59
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  59
caggtgcagc tacagcagtg gggcgcagga ctgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctatggtgg gtccttcagt ggtcactact ggagctggat ccgccagccc      120

ccagggaagg gactggagtg gattggggaa atcaatcaca gtggaagcac caactacaac      180

ccgtccctca agagtcgagt caccatatca gtagacacgt ccaagaacca gttctccctg      240

aagctgagct ctgtgaccgc cgcggacacg gctgtgtatt actgtgcgag acccccccaa      300

gcagctcgta ttcattacta ctactacatg gacgtctggg gcaaagggac cacggtcacc      360

gtctcctca                                                              369


<210>  60
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  60
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataattact ggcctcccct cactttcggc      300

ggagggacca aggtggagat caaa                                             324


<210>  61
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  61
gaagtgcagc tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgaactgggt ccggcaacct      120

ccagggaagg gcctggagtg ggtctcaggt attagttgga atagtgatag cataggctat      180

gcggactccg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agctgaggac acggccatgt attactgtgc aaaaggaagg      300

ggtgctggtt atacttccta catggacgtc tggggcaaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  62
<211>  326
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  62
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgagg gaaacaacat tggaagtaaa agtgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt ctatgatgat agcggccggc cctcagggat ccctgaacga      180

ttctctggtt ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actatttctg tcaggtgtgg gatagtagta gtgatcatca tgtggttttc      300

ggcggaggga ccaagctgac cgtcct                                           326


<210>  63
<211>  300
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  63
cctacacgac gctcttccga tctgggggtc actggatcgg ctgggtgcgc cagatgcccg       60

ggaaaggcct ggagtggatg gggatcatct atcctggtga ctctgatacc agatatagcc      120

cgtccttcca agggcaggtc accatctcag ccgacaagtc catcagcacc gcctacctgc      180

agtggagcag cctgaaggcc tcggacaccg ccatgtatta ctgtgcgagt gccctcagag      240

agcgaggcgt acagctgtgg tcagtttggg gccagggaac cctggtcacc gtctcctcag      300


<210>  64
<211>  330
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  64
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtacactg gtaccagcag      120

cttccaggaa cagcccccaa actcctcatc tttattaact ccaatcggcc ctcaggggtc      180

cctgaccgct tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagcagcct gggtgccttg      300

ttcggcggag ggaccaagct gaccgtccta                                       330


<210>  65
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  65
gaagtgcagc tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgcactgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagttgga atagtggtag catagcctat      180

acggactctg tgaagggccg attcaccatc tccagagata acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agctgaggac acggccttgt attactgtgc aaaagcacac      300

tcgactggac accaatacta ctacggtatg gacgtctggg gccaagggac cacggtcact      360

gtctcctca                                                              369


<210>  66
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  66
gacatccaga tgacccagtc tccatcctcc ttgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctttttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcattcaatt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaatct      240

gaagattttg caacttacta ctgtcaacag agttacaata ccccttacac ttttggccag      300

gggaccaagc tggagatcaa a                                                321


<210>  67
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  67
gaagtgcagc tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgcactgggt ccggcaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagttgga atagtggtag cataggctat      180

gcggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctatat      240

ctgcaaatga acagtctgag agctgaggac acggccttgt attactgtgc aaaagtgtcg      300

tccattacta gcctattggg atactacttt gactcctggg gccagggaac cctggtcacc      360

gtctcctca                                                              369


<210>  68
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  68
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agctacttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagattttg cagtttatta ctgtcagcac cgtagcaact ggcctccgag gctcactttc      300

ggcggaggga ccaaggtgga gatcaaa                                          327


<210>  69
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  69
caggtccagc tggttcaatc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaaga cttctggaga cacctccagc agttatactg tcggctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaagg atcatcccta tccttggtat agcatactcc      180

gcacagaagt tccagggcag actcacgatt accgcggaca aatccacgag cacatcctac      240

atggagctga gcagcctgag atctgaggac acggccgttt attactgtgc gagaggggtg      300

gtagctgcta ctccgggttg gttcgacccc tggggccagg gaaccctggt caccgtctcc      360

tca                                                                    363


<210>  70
<211>  318
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  70
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagtcacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcggtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tataataact tcctcacttt cggcggaggg      300

accaaggtag agatcaaa                                                    318


<210>  71
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  71
gaggtgcagc tggtggagtc cgggggaggc ttagttcagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctactgga tgcactgggt ccgccaagtt      120

ccagggaagg ggctggtgtg ggtctcacgt attaatagtg atgggagtag cacaagctac      180

gcggactccg tgaagggccg attcaccatc tccagagaca acgccaagaa cacgctgtat      240

ctggaaatga acagtctgag agcccaggac acggctgttt attactgtgc aggttccccg      300

tggctacgag gcgacattga ctactggggc cagggaaccc tggtcaccgt ctcctca         357


<210>  72
<211>  336
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  72
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccg gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggataacc aaaggccctc tggggtccct      180

gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcac catctctggg      240

ctgatgactg aggacgaggc tgactactac tgtcagtctt atgatggcag caatcatgct      300

gtggtattcg gcggagggac caagctgacc gtccta                                336


<210>  73
<211>  390
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  73
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggata caccttcacc gactactata tgcactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcaacccta acagtcgtgg cacaaactat      180

gcacagaagt ttcagggcag ggtcactatg accagggaca cgtccatcag cacagtctac      240

atggagctga gcaggctgac atctgacgac acggccgtct attactgtgc gagagtggtg      300

gtcctcggct atggccgccc aaacaattac tatgatggta ggaatgtgtg ggactactgg      360

ggccagggaa ccctggtcac cgtctcctca                                       390


<210>  74
<211>  330
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  74
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcatcatc       60

tcttgttctg gaagcagctc caacatcgga agtaatactg taaagtggta tcatcagctc      120

ccaggaacgg cccccaaact cctcatctgt agtaataatc agcggccctc aggggtccct      180

gaccgattct ctggctccaa gtctgacacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctgatta ttactgtgca gcatgggatg acagcctgaa tgctttggta      300

ttcggcggag ggaccaagct gaccgtccta                                       330


<210>  75
<211>  351
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  75
caggtcacct tgagggagtc tggtcctgcg ctggtgaaac ccacacagac cctctcactg       60

acctgcacct tctctgggtt ctcactcggc actagtggaa tgtgtgtgag ctggatccgt      120

cagcccccag ggaaggccct ggagtggctt gcacgcattg attgggatga tgataaatac      180

tacagcacat ctctgaagac caggctcacc atctccaagg acacctccaa aaaccaggtg      240

gtccttacaa tgaccaacat ggaccctgtg gacacagcca cgtattactg tgcacggggg      300

gtggttactt atgactattg gggccaggga accctggtca ccgtctcctc a               351


<210>  76
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  76
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtgacc       60

atcacttgcc gggcaagtca gagcattgcc ggctatttaa actggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatggt acaaccagtt tgcaaagtgg ggtcccagta      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta cccctggcac cttcggccaa      300

gggacacgac tggagattaa a                                                321


<210>  77
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  77
caggtccagc tggtgcaatc aggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggaga caccttcagc agctatacta tcaactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaagg atcatcccta tccttggtat accaaactac      180

gcacagaaat tccagggcag agtcaccatt accgcggaca aatccacgag cacagccttc      240

atggagctga gcagcctgag atctgaggac acggccgtct attactgtgc gagagggagg      300

ggctacagta actacggggc ctcctactac atggacgtct ggggcaaagg gaccacggtc      360

accgtctcct ca                                                          372


<210>  78
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  78
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaac cactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaaccgg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcaccag cctgcagcct      240

gaagatgttg caacatatta ctgtcaacag tctgataatc tccccatgta cacttttggc      300

caggggacca agctggagat caaa                                             324


<210>  79
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  79
gaagtgcagc tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgaactgggt ccggcaacct      120

ccagggaagg gcctggagtg ggtctcaggt attagttgga atagtgatag cataggctat      180

gcggactccg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agctgaggac acggccatgt attactgtgc aaaaggaagg      300

ggtgctggtt atacttccta catggacgtc tggggcaaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  80
<211>  326
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  80
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgagg gaaacaacat tggaagtaaa agtgtgcact ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt ctatgatgat agcggccggc cctcagggat ccctgaacga      180

ttctctggtt ccaactctgg gaacacggcc accctgacca tcagcagggt cgaagccggg      240

gatgaggccg actatttctg tcaggtgtgg gatagtagta gtgatcatca tgtggttttc      300

ggcggaggga ccaagctgac cgtcct                                           326


<210>  81

<400>  81
000

<210>  82

<400>  82
000

<210>  83
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  83
caggtgcagc tggcgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg ctgctggata caccttcacc agttatgata tcaactgggt gcgacaggcc      120

actggacaag ggcttgagtg gatggggtgg atgaactcta acagtggtaa cgcaggctat      180

gcacagaagt tccagggcag agtcactatg accagggaca cctccacaag tacagcctac      240

atggagttga gcagcctgac atctgatgac acggccgtgt attattgtgc gagaatgcgc      300

accggctggc ccacacatgg ccgcccggat gacttctggg ggcggggaac cctggtcacc      360

gtctcctca                                                              369


<210>  84
<211>  330
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  84
cagtctgtgc tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcaactc caacatcgga agttatactg taaactggta ccagcagttc      120

ccaggaacgg cccccaaact cctcatttat gataataatc agcggacctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tggccatcag tgggctccag      240

tctgaggatg aggctaatta ttactgttta gtatgggatg acagcctgaa tggcctggta      300

ttcggcggag ggaccaagct gaccgtccta                                       330


<210>  85
<211>  365
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  85
gaagtgcagc tggtggagtc tggaggaggc ttggtccagc cgggggggtc cctgagactc       60

tcctgtgcag cctctgggtt caccgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagtt atttatcccg gtggtagcgc attctacgca      180

gactccgtga agggccgatt caccatctcc agacacaatt ccaacaacac actgtgtctt      240

caaatgaaca gcctgcgaac tgaggacacg gccgtgtatt attgtgcgag atcttacgat      300

attttgactg gttatagaga tgcttttgat atctggggcc aagggacaat ggtcaccgtc      360

tcttc                                                                  365


<210>  86
<211>  336
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  86
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg tcaggttctg atgtacactg gtaccagcag      120

cttccaggaa cagcccccaa actcctcatc tatggcaaca ccaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagcaggct gagtggtttt      300

gtggtattcg gcggagggac caagctgacc gtccta                                336


<210>  87
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  87
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggact caccgtcagt agcaactaca tgagttgggt ccgccaggct      120

ccagggaagg ggctggagtg cgtctcagtt atttatgccg gtggtaatac atactacgca      180

gactccgtga agggcagatt caccatctcc agagacaatt ccaagaacac gctgtatctt      240

caaatgaaca gcctgagagc cgaggacacg gctgtgtatt actgtgcgag aggcgatggt      300

ggttattact caccctttga ctactggggc cagggaaccc tggtcaccgt ctcctca         357


<210>  88
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  88
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaaggtcct gatctatgct gcatccacta tgcaaagtgg ggtcccatca      180

aggttcaggg gcagtggctc tgggacagat ttcactctca ccatcagcag tctgcaactt      240

gaggattttg caacttacta ctgtcaacag agttacagta cccctcagac gtttggccaa      300

gggaccaagg tggaaatcaa a                                                321


<210>  89
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  89
caggtgcagt tacagcagtg gggcgcaggg ctgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctctggtgg gtccttcagt gcttactact ggagctggat ccgccagccc      120

ccagggaagg ggctggagtg gattggggaa atcaatcata gtggaagcac caactacaac      180

ccgtccctca ggagtcgagt caccatatca gtagacacgt ccaagaacca attctccctg      240

aagctgagct ctgtgaccgc cgcggacacg gctgtgtatt actgtgcgag agtgggttat      300

tcccaagggt actactacta ctacatggac gtctggggca aagggaccac ggtcaccgtc      360

tcctca                                                                 366


<210>  90
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  90
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc aactatttaa attggtatca gcagaaaccg      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccctca      180

aggttcagtg gcagtggatc tgggacagat ttctctctca ccatcagcag tctgcaacct      240

gaagattttg caacttactc ctgtcaacag agttacacta ccctcctcac tttcggcgga      300

gggaccaagg tggagatcaa a                                                321


<210>  91

<400>  91
000

<210>  92

<400>  92
000

<210>  93
<211>  375
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  93
caggtccagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatagta tcacctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaagg atcatccctg tccttggtat agcaaactac      180

gcacagaagt tccaggacag agtcacgatt acggcggaca aatccacgag cacagcctac      240

atggagctga gcagcctgag atctgaggac acggccgtct attactgtgc gagagtgggc      300

gtgagtggtt ttaaaagtgg ctcgaactgg tacttcgatc tctggggccg tggcaccctg      360

gtcactgtct cctca                                                       375


<210>  94
<211>  333
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  94
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccctc       60

tcctgcactg ggagcaactc caacatcggg gcaggttatg atgtacactg gtaccagcag      120

cttccaggaa cagcccccaa actcctcatc tatggtaata gcaatcggcc ctccggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagcagcct gagtgattcg      300

gtgttcggcg gagggaccaa ggtgaccgtc cta                                   333


<210>  95

<400>  95
000

<210>  96

<400>  96
000

<210>  97
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  97
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg catctggata caccttcacc agctactata tgcactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaata atcaaccctg gtggtggtag tacaacctac      180

gcacagaagt tccagggcag agtcaccatg accagtgaca cgtccacgag cacagtctac      240

atggagctga gcagcctgag atctgaggac acggccatgt attactgtgc gagaggggca      300

attcccccaa atagcagagc cgaaattgac tactggggcc agggaaccct ggtcaccgtc      360

tcctca                                                                 366


<210>  98
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  98
gaaatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagtcacc       60

ctctcctgca gggccagtca gagtgttagc agcaacttag cctggtgcca gcagaaacct      120

ggccaggctc ccaggctcct catctatggt gcatccacca gggccactgg tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcaa tattataact ggccgctcac tttcggcgga      300

gggaccaagg tggagatcaa a                                                321


<210>  99
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  99
gaggtgcagc tggtggagtc tgggggaggt gtggtacggc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt catctttgat gattatgaca tgacctgggt ccgccaagct      120

ccagggaagg ggctggagtg ggtctctggt attagttgga atggtggtaa cacaggttat      180

gcagactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agccgaggac acggccttgt atcactgtgc agtgattatg      300

tctccaatcc cccgttatag tggctacgat tgggcgggtg gtgcttttga tatctggggc      360

caagggacaa tggtcaccgt ctcttca                                          387


<210>  100
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  100
tcttctgagc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagcct cagaagctat tatgcaagct ggtaccagca gaagccagga      120

caggtcccta tacttgtcat ctatgataaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattactg taactcccgg gacagcagtg gtaacgccgt ggtgttcggc      300

ggagggacca agctgaccgt ccta                                             324


<210>  101
<211>  381
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  101
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt aactatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atgtcatatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtat attactgtgc gaaaaattta      300

ggaccctatt gtagtggtgg tacctgctat tccttagttg gtgactactg gggccaggga      360

accctggtca ccgtctcctc a                                                381


<210>  102
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  102
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattagc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgctaatc tcccattcac tttcggccct      300

gggaccaaag tggatatcaa a                                                321


<210>  103

<400>  103
000

<210>  104

<400>  104
000

<210>  105

<400>  105
000

<210>  106

<400>  106
000

<210>  107
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  107
gaagtgcaac tggtggagtc tgggggaggc ttggtacagc ctggcaggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatgcca tgcattgggt ccggcaagct      120

ccagggaagg gcctagagtg ggtctcaggt atcagttgga acagtggtac cataggctat      180

gcggactctg tgaagggccg attcatcatc tccagagaca acgccaagaa ctccttgtat      240

ctgcaaatga acagtctgag acctgaggac acggccttgt attactgtgc aaaagatata      300

atacgtcagg gcgaagacgg tatggacgtc tggggccaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  108
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  108
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gaacattgcc agctatttga attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc ggggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagagtttg caacttacta ctgtcaacag agttacagta ccccgtggac gttcggccaa      300

gggaccaagg tggaaatcaa a                                                321


<210>  109
<211>  354
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  109
gaggtgcaac tgttggagtc tgggggaggc ttgatacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagc aactatgcca tgtcctgggt ccgccaggcc      120

ccagggaagg ggctggagtg ggtctcaggt attattagta ccagtggtgg tgccacatac      180

aacgcagact ccgtgagggg ccggttcacc acctccaggg acaattccaa gaacatactg      240

tatctgcaaa tgaacagcct cagaggcgag gacacggccg tttattactg tgtgaaaggt      300

ctctttgact ggttcccgct ctggggccaa gggacaatgg tcaccgtctc ttca            354


<210>  110
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  110
gacatagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagagccatc       60

ctctcctgca gggccagtca gagtgttaga agcaatttag cctggtacca gcagaaacct      120

ggccaggctc ccaggctcct catctctggt gcatccacca gggccactgc tatcccagcc      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcaccag cctgcagtct      240

gaagattgtg cagtttatta ctgtcaccag tataataact ggcctcagac gttcggccaa      300

gggaccaagg tggaaatcaa a                                                321


<210>  111
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  111
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt aggcattgga tgacctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaagcaag atggaagtga gaaatactat      180

gtggactctg tgaagggccg actcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagactgggg      300

ttctattacg gtggagccga ctactggggc cagggaaccc tggtcaccgt ctcctca         357


<210>  112
<211>  336
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  112
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccg gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctct gaggataacc aaagaccctc tggggtccct      180

gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatggcat caatcgggca      300

tgggtgttcg gcggagggac caagctgacc gtccta                                336


<210>  113
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  113
aacgtgcaat tagtggagtc tgggggaggc ttggttcagc ctggcgggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttcat cattatgcca tgcactgggt ccgacaagct      120

ccagggaagg gcctggagtg ggtctcaggt attagtggga gtagtgatta cagagcctat      180

gcggactctc tgaagggccg attcaccatc tccagagact acgccaagaa ctccctgtgg      240

ctgcaaatga acagtctgac atctgaggac acggccttct attactgtgc aaagggcgtt      300

gactatggcg gcaaacttgc ctactttgac tcctggggcc agggaaccct ggtcaccgtc      360

tcctca                                                                 366


<210>  114
<211>  336
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  114
gatattgtga tgactcagtc tccactctcc ctgcccgtca cccctggaga gccggcctcc       60

atctcctgca ggtctagtca gagcctcctg catagtcttg gatacaactc tttgagttgg      120

tacctgcaga agccagggca gtctccacac ctcctgatct atttgggctc taatcgggcc      180

tccggggtcc ctgacaggtt cagtggcagt ggatcagcca cagactttac actgaaaatc      240

agcagattgg aggctgagga tgttggcgtt tattactgca tgcaagctct acaaactccc      300

ctcaccttcg gccaagggac acgactggag attaaa                                336


<210>  115
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  115
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt cagcttcagt agctatgtta tgaactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcag taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa tacactgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagagacatt      300

gatagtggct acgatcctac ccccgttttt gactactggg gccagggaac cctggtcacc      360

gtctcctca                                                              369


<210>  116
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  116
gacatccaga tgacccagtc tccatcctcc ctgtctgcat gtgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaaggcc ctaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagac ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagtt ccctttcgat caccttcggc      300

caagggacac gactggagat taaa                                             324


<210>  117
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  117
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctacgacc tgcactgggt ccgccaaggt      120

acaggaaaac gtctggagtg ggtctcagct attggtactg ctggtgacac atactatcta      180

ggctccgtga agggccgatt caccatctcc agagaaaatg ccaagaactc cttgtatctt      240

caaatgaaca gcctgagagc cggggacacg gctgtgtatt actgtgcaag agtcctctat      300

gatagtagtg gtttttacaa ctggttcgac ccctggggcc agggaaccct ggtcaccgtc      360

tcctca                                                                 366


<210>  118
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  118
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgttggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattagc agctatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccagtt tggaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacgaaa tccctccgtg gacgttcggc      300

caagggacca aggtggaaat caaa                                             324


<210>  119
<211>  348
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  119
gaggtgcagc tggtggagtc tggaggaggc ttgatccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctgaggt caccgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcactt atttatagcg gtggtactac atactacgca      180

gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac cctgtatctt      240

caaatgaaca gcctgagagc cgaggacacg gccgtgtatt actgtgcgag agactttcta      300

cggtggcacg acctctgggg ccagggaacc ctggtcaccg tctcctca                   348


<210>  120
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  120
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaac aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatta      180

aggttcagtg gaagtggatc tgggacagat tttattttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgataatc tccctccagt tttcggcgga      300

gggaccaagg tggagatcaa a                                                321


<210>  121
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  121
caggtccagc tggtgcaatc aggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggaga caccttcagc agctatacta tcaactgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaagg atcatcccta tccttggtat accaaactac      180

gcacagaaat tccagggcag agtcaccatt accgcggaca aatccacgag cacagccttc      240

atggagctga gcagcctgag atctgaggac acggccgtct attactgtgc gagagggagg      300

ggctacagta actacggggc ctcctactac atggacgtct ggggcaaagg gaccacggtc      360

accgtctcct ca                                                          372


<210>  122
<211>  333
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  122
cagtctgtgc tgacgcagcc gccctcagtg tctggggccc cagggcagag ggtcaccatc       60

tcctgcactg ggagcagctc caacatcggg gcaggttatg atgtacactg gtaccagcag      120

cttccagaaa cagcccccaa actcctcatc tatgctaaca gcaatcggcc ctcaggggtc      180

cctgaccgat tctctggctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgagg atgaggctga ttattactgc cagtcctatg acagcagcct gagtggttcg      300

gtattcggcg gagggaccaa gctgaccgtc cta                                   333


<210>  123
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  123
cagctgcagc tacaggagtc gggcccagga ctggtgaagc cttcggagac cctatccctc       60

acctgcactg tctctggtgg ctccatcagc agtagtagtt actactgggg ctggatccgc      120

cagcccccag ggaacgggct ggagtggatt gggagtatct attatagtgg gagcacctac      180

tacaacccgt ccctcaaggg tcgagtctcc atatccgtag acacgtccaa gaaccagttc      240

tccctgaagc tgagctctgt gaccgccgca gacacggctg tctattactg tgcgagaatc      300

ttagtaattt ttactttaaa ctggttcgac ccctggggcc agggaaccct ggtcaccgtc      360

tcctca                                                                 366


<210>  124
<211>  330
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  124
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccatc       60

tcctgcaccg gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggataacc aaagaccctc tggggtccct      180

gatcggttct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatagcgg caatcccata      300

ttcggcggag ggaccaagct gaccgtccta                                       330


<210>  125

<400>  125
000

<210>  126

<400>  126
000

<210>  127
<211>  348
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  127
gaggtgcagc tggtggagtc tggaggaggc ttgatccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctgaggt caccgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcactt atttatagcg gtggtactac atactacgca      180

gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac cctgtatctt      240

caaatgaaca gcctgagagc cgaggacacg gccgtgtatt actgtgcgag agactttcta      300

cggtggcacg acctctgggg ccagggaacc ctggtcaccg tctcctca                   348


<210>  128
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  128
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattaac aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatta      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgataatc tccctccagt tttcggcgga      300

gggaccaagg tggagatcaa a                                                321


<210>  129
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  129
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccgtcagc agtggtagtt actactggag ctggatccgg      120

cagcccccag ggaagggact ggagtgcatt gggtatatct attacagtgg gagctccaac      180

tacaacccct ccctcaagag tcgagtcacc atatcagtag acacgtccaa gaaccagttc      240

tccctgaaga tgagctctgt gaccgctgcg gacacggccg tatattactg tgcggggagc      300

cctgtccctc ccacgattgt gggagcttcg tactggggcc agggaaccct ggtcaccgtc      360

tcctca                                                                 366


<210>  130
<211>  336
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  130
aattttatgc tgactcagcc ccactctgtg tcggagtctc cggggaagac ggtaaccttc       60

tcctgcaccg gcagcagtgg cagcattgcc agcaactatg tgcagtggta ccagcagcgc      120

ccgggcagtg cccccaccac tgtgatctat gaggataacc aaagaccctc tggggtccct      180

gatcgattct ctggctccat cgacagctcc tccaactctg cctccctcac catctctgga      240

ctgaagactg aggacgaggc tgactactac tgtcagtctt atgatggcat caatcggtgg      300

ctggtattcg gcggagggac caagctgacc gtccta                                336


<210>  131
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  131
gaggtgcagc tggtgcagtc tggagcagag gtgaaaaagc ccggggagtc tctgaagatc       60

tcctgtaagg gttctggata cagctttacc agctactgga tcgactgggt gcgccagatg      120

cccgggaaag gcctggagtg gatggggatc atttatcctg gtgactctga taccagatat      180

agcccgtcct tccaaggcca ggtcaccatc tcagccgaca agtccaccag caccgcctac      240

ctgcagtgga gcagcttgaa ggcctcggac accgccatgt attactgtgc gagacgtgga      300

gaagcagctg gtatttggta cttcgatctc tggggccgtg gcaccctggt cactgtctcc      360

tca                                                                    363


<210>  132
<211>  351
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  132
cagcctgtgc tgactcagcc accttctgca tcagcctccc tgggagcctc ggtcacactc       60

acctgcaccc tgagcagcgg ctacagtaat tataaagtgg actggtacca gcagagacca      120

gggaagggcc cccggtttgt gatgcgagtg ggcactggtg ggattgtggg atccaagggg      180

gatggcatcc ctgatcgctt ctcagtcttg ggctcaggcc tgaatcggta tctgacaatc      240

aagaacatcc aagaagagga tgagagtgac taccactgtg gggcagacca tggcagtggg      300

agcaacttcg agtatgtggt attcggcgga gggaccaagc tgaccgtcct a               351


<210>  133
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  133
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt caccgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagtt atttatagcg ctggtagcac atactacgca      180

gactccgtga agggcagatt cagcatctcc agagacaagt ccaagaacac gctgtatctt      240

caaatgaaca gcctgagagc cgaggacacg gctgtatatt actgtgcgaa agaaggtgga      300

tcggggagcc tccgctacta ctactacggt atggacgtct ggggccaagg gaccacggtc      360

accgtctcct ca                                                          372


<210>  134
<211>  330
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  134
cagtctgtgg tgactcagcc accctcagcg tctgggaccc ccgggcagag ggtcaccatc       60

tcttgttctg gaagcagctc caacatcgga tataatattg taaactggta ccagcagctc      120

ccaggaacgg cccccaaact cctcatctat agtaataatc agaggccctc aggggtccct      180

gaccgattct ctggctccaa gtctggcacc tcagcctccc tgtccatcag tgggctccag      240

tctgaggatg aggctgatta ttactgtgca gcatgggatg acagcctgaa tggttatgtc      300

ttcggaactg ggaccaaggt caccgtccta                                       330


<210>  135
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  135
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acgtatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacactatat      240

ctgcaaatga tcggcctgag agctgaggac acggctgtgt attactgtgc gagagattgg      300

gcacctacgt actacgatat gccgagtgct tttgatatct ggggccaagg gacaatggtc      360

accgtctctt ca                                                          372


<210>  136
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  136
tcctatgtgc tgactcagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaaataaa ggtgtgcatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt cgatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgatca tcagcagtgt cgaagtcggg      240

gatgaggccg acttttactg tcaggtgtgg gatagtagta gtgatcatcc gggggtgttc      300

ggcggaggga ccaagctgac cgtccta                                          327


<210>  137
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  137
gaggtgcagc tggtggagtc tgggggaggc ttggtacagc ctggagggtc cctgagactc       60

tcctgtgaag cctctggatt caccttcagt agttctgaaa tcaactgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtttcacac attagtagta gtggtagtat catatactac      180

gcagactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgttt attactgtgc gaggagatct      300

tatagaagca gctggtacta ctactacggt atggacgtct ggggccaagg gaccacggtc      360

accgtctcct ca                                                          372


<210>  138
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  138
gacatccagt tgacccagtc tccatccttc ctgtctgctt ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gggcattagc agttatttag cctggtatca gcaaaaacca      120

gggaaagccc ctaagctcct gatctatgct gcatccactt tgcaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca caatcagcag cctgcagcct      240

gaagattttg caacttatta ctgtcaacag cttaatagtt accccgtgac gttcggccaa      300

gggaccaagg tggaaatcaa a                                                321


<210>  139
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  139
caggtgcagc tggcggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggaatg ggtggcagtt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagaagcacg      300

agtgggagct actactacgg tatggacgtc tggggccaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  140
<211>  336
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  140
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt gattataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga atattactgc agctcatata caagcagcag cactctactt      300

tatgtcttcg gaactgggac caaggtcacc gtccta                                336


<210>  141
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  141
caggtgcagc tggtgcagtc tggggctgag gtgaggaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcagctgggt gcggcaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatccctg tctttggtac agcaaactac      180

gcacagaagt tccagggccg agtcacgatt accgcggaca aatccacgag cacagccttc      240

atggagctga acagcctgag atctgaggac acggccgtct attactgtgc gagaattggg      300

agctaccctg aatacttcca gcactggggc cagggcaccc tggtcaccgt ctcctca         357


<210>  142
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  142
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcttcttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagattttg cagtttatta ctgtcactac cgtagcaact ggcctccggt tctcactttc      300

ggcggaggga ccaaggtgga gatc                                             324


<210>  143
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  143
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcatctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtac aacaaactac      180

gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgag cacagcctac      240

gtggaactga gcagcctgag atctgaggac acggccgtgt attattgtgc gagaataggc      300

cattttgata gtagtggtta ttacttagac tactggggcc agggaaccct ggtcaccgtc      360

tcctca                                                                 366


<210>  144
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  144
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcttcttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca ggcccactgg catcccagcc      180

aggttcactg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagattttg cagtttatta ctgtcagcac cgtaccaact ggcctccctt attcactttc      300

ggccctggga ccaaagtgga tatcaaa                                          327


<210>  145
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  145
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agttatgctc tgttctgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atttcatatg atggaaataa taaatactac      180

gcagactccg tgaggggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag acctgaggac acggctgtgt attactgtgc gagaccatat      300

actgggagct acaagagcta catggacgtc tggggcaaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  146
<211>  339
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  146
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagctcca acaataagaa ctccttagct      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtatattact gtcagcaata ttatagtatt      300

tcttggacgt tcggccaagg gaccaaggtg gaaatcaaa                             339


<210>  147
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  147
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcacagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagc agtggtggtt acttctggag ctggatccgc      120

cagcacccag ggaagggcct ggagtggatt gggtccatct attacagtgg gagcacctac      180

tacaacccgt ccctcaggag tcgaattacc atatcagtag acacgtctaa gaaccagttc      240

tccctgaagc tgagctctgt gactgccgcg gacacggccg tgtattactg tgcgaggggg      300

ggttcgggga gttattctct ttttgactac tggggccagg gaaccctggt caccgtctcc      360

tca                                                                    363


<210>  148
<211>  324
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  148
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattacc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagattttg caacatatta ctgtcaacag tatgataatc tctactctgt acactttggc      300

caggggacca agctggagat caaa                                             324


<210>  149
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  149
caggtgcagc tggtggagtc cgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt aggcatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcaa taaatactat      180

gcagactccg tgaagggccg attcgccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag acctgaggac acggctgtat attactgtgc gagagatccg      300

agcccgttag tgcttattac ttcaattgac tactggggcc agggaaccct ggtcaccgtc      360

tcctca                                                                 366


<210>  150
<211>  323
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  150
tcctatgagc tgacacagcc accctcggtg tcagtgtccc caggacagac ggccaggatc       60

acctgctctg gagatgcatt gccaaggcaa tatacttatt ggtaccagca gaagccaggc      120

caggcccctg tgttggtgat atataaagac agtgagaggc cctcagggat ccctgagcga      180

ttctctggct ccagctcagg gacaacagtc acgttgacca tcagtggagt ccaggcagaa      240

gacgaggctg actattactg tcaatcagca gacaccattg gtacttattg ggtattcggc      300

ggagggacca agctgaccgt cct                                              323


<210>  151
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  151
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt agctattgga tgacctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaagcaag atggaagtga gaaatactat      180

gtggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtct      240

ctgcaaatga acagcctgag agtcgaggac acggctgtgt attattgtgt gagactgggg      300

gtcagcagct ggtactttga ctactggggc cagggaaccc tggtcaccgt gtcctca         357


<210>  152
<211>  318
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  152
tcctatgagc tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggggataaa tatgcttgct ggtatcagca gaagccaggc      120

cagtcccctg tgctggtcat ctatcaagat accaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg ggcagtagca ggggagtgtt cggcggaggg      300

accaagctga ccgtccta                                                    318


<210>  153
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  153
caggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtgc agcaaactac      180

gcacagaact tccagggcag agtcacgatt accgcggacg aatccacgag cacaggctac      240

atgcaactga gcagcctgag atttgaggac acggccgtgt attactgtgc gagaacgtct      300

cactatgata gtagtggttc ctattttgaa tactggggcc agggaaccct ggtcaccgtc      360

tcctca                                                                 366


<210>  154
<211>  326
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  154
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agctacttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagaccct      240

gaagattttg cagtttatta ctgtcacaag cgtagcaact ggcctccttc gctcactttc      300

ggcggaggga ccaaggtgga gatcaa                                           326


<210>  155

<400>  155
000

<210>  156

<400>  156
000

<210>  157
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  157

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Ala Ser Gly Phe Thr Phe Ser Phe Tyr 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Gly Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Ser Gly Ser Ser Trp Asp Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  158
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  158

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Tyr Gln Gln Arg Pro Gly Gln Ser Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Gln Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Gly Val 
                85                  90                  95      


Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105     


<210>  159
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  159

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Arg Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Gly Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Asn Trp Asn Gly Gly Ser Thr Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr His Cys 
                85                  90                  95      


Ala Arg Arg Arg Ser Ser Ser Arg Tyr Ser Ser Gly Trp Tyr Met Tyr 
            100                 105                 110         


Tyr Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  160
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  160

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Thr Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Asn Leu Leu Ile 
        35                  40                  45              


Tyr Glu Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Thr Tyr Ser Gly 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  161
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  161

Gln Ile Thr Phe Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Glu 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Val Ser Thr Ser 
            20                  25                  30          


Gly Glu Gly Val Gly Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Val Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Arg Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Leu Trp Phe Arg Asp Ala Phe Asp Ile Trp Gly Gln 
            100                 105                 110         


Gly Thr Thr Val Thr Val Ser Ser 
        115                 120 


<210>  162
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  162

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Arg Gln Ser Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Thr Tyr Ser Thr Phe Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Asn Val Glu Ile Lys 
            100                 105         


<210>  163
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  163

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Trp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Ser Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Tyr Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Gly Ser Ser Ser Trp Tyr Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  164
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  164

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Val Val Val Ile Tyr 
        35                  40                  45              


Gln Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Ala Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  165
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  165

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Thr Tyr Tyr Cys Gly Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Thr Tyr Tyr Gly Gly Ser Thr Leu Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Arg Gly Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Arg Gly Asn Tyr Tyr Asp Ser Lys Asn Trp Phe Asp Pro 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  166
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  166

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Val Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Ala 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro Pro 
                85                  90                  95      


Met Tyr Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  167
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  167

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Val Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser His 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Trp Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Ser 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Ser Ala Asp Ile Ser Ser Arg Leu Asp Tyr Trp Gly Arg 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  168
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  168

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Thr Lys Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Ser Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Asp Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Met Ala Thr Leu Thr Ile Ser Gly Ala Gln Val Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Tyr Ser Thr Asp Ser Ser Gly Asn Val 
                85                  90                  95      


Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105     


<210>  169
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  169

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Gly Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ala Asp Thr Met Val Arg Gly Thr Tyr Phe Glu Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  170
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  170

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Cys Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Arg Ala Val Leu Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  171
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  171

Gln Ile Thr Leu Lys Glu Ser Gly Pro Thr Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Thr Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Ser Thr Ser 
            20                  25                  30          


Gly Val Gly Val Ala Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Leu Ile Tyr Trp Asp Asp Asp Lys Arg Tyr Ser Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Leu Thr Ile Thr Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala His Arg Leu Pro Thr Pro Gln Leu Leu Pro Ser Phe Glu Asn 
            100                 105                 110         


Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  172
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  172

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Glu Ala Pro Arg Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Gly Ser Ser Asn Ile Gly Asn Asn 
            20                  25                  30          


Ala Val Asn Trp Tyr Gln Gln Leu Pro Gly Lys Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Tyr Asp Asp Leu Leu Pro Ser Gly Val Ser Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ser Trp Asp Asp Ser Leu 
                85                  90                  95      


Ile Gly Pro Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  173
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  173

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Val Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Val Trp Val 
        35                  40                  45              


Ser Arg Ile Asn Ser Asp Gly Ser Ser Thr Ser Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Val Glu Gln Leu Ala His Met Val Asp Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  174
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  174

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Asn Gln Tyr Ala 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Ser Ser Gly Thr Ser 
                85                  90                  95      


Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  175
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  175

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ile Asn Lys Tyr Tyr Ala Asp Ala Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Pro Arg Ser Gly Ser Tyr Tyr Ala Tyr Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  176
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  176

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Asn Tyr 
            20                  25                  30          


Leu Ala Trp Phe Gln Gln Lys Pro Gly Lys Ala Pro Lys Ser Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Lys Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Val Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ser His Pro Pro 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  177
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  177

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Tyr Tyr 
            20                  25                  30          


Pro Met His Trp Leu Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Val Ala Val Thr Ser Tyr Asp Gly Thr Asn Lys Tyr Tyr Ala Asp 
    50                  55                  60                  


Ser Val Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr 
65                  70                  75                  80  


Leu Tyr Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Tyr Cys Ala Arg Gly Gly Ala Thr Asn Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  178
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  178

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Asn Ile Thr Cys Gly Gly Asn Asn Ile Gly Arg Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Ser Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


Pro Glu Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  179
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  179

Glu Ala Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Ser 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Asn Val Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Thr Lys Ala Ser Arg Tyr Cys Ser Ser Thr Ile Cys Tyr Trp Asn Trp 
            100                 105                 110         


Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125     


<210>  180
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  180

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Ser Leu Gln Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Arg Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Ser Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Thr 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105     


<210>  181
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  181

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Glu Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Tyr Ile Ser Ser Ser Gly Ser Ala Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Glu Ala Arg Ser Arg Tyr Phe Asp Trp Leu Pro Ser Tyr Tyr 
            100                 105                 110         


Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125     


<210>  182
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  182

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Ile Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Asp Val Ser Asn Arg Pro Ser Gly Val Ser Thr Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  183
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  183

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Thr Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Asn Thr Gly Asn Pro Thr Tyr Ala Gln Gly Phe 
    50                  55                  60                  


Thr Gly Arg Phe Val Phe Ser Leu Asp Thr Ser Val Asn Thr Ala Phe 
65                  70                  75                  80  


Leu His Ile Gly Ser Leu Lys Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gln Asp Ser Gly Tyr Pro Thr Tyr Tyr Tyr Tyr Tyr Met 
            100                 105                 110         


Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125 


<210>  184
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  184

Asp Ile Val Met Thr Gln Thr Pro Leu Ser Leu Ser Val Thr Pro Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asp Gly Lys Thr Tyr Leu Tyr Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Glu Val Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ser 
                85                  90                  95      


Ile Gln Pro Pro Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 110         


<210>  185
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  185

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Ala Trp Val 
        35                  40                  45              


Ala Leu Ile Ser Tyr Asp Gly Tyr Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Ile Ser Arg Ile Asn Ser Lys Asn Thr Leu Ser 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Ser Ala Gly Asn Tyr Tyr Tyr Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  186
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  186

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Thr Ile Thr Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Leu Lys Ser Gly Arg Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  187
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  187

Gln Val His Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Asn Asp Glu Phe Asn Lys Phe Tyr Ala Asn Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Val Tyr 
65                  70                  75                  80  


Leu Gln Leu Asn Ser Leu Arg Thr Glu Asp Thr Ala Arg Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Gly Asp Gly Ser Gly Trp Ala Trp Asp Gly Asp Asn Pro 
            100                 105                 110         


Pro Thr Asp Tyr Trp Gly Gln Gly Thr Leu Val Ile Val Ser Ser 
        115                 120                 125         


<210>  188
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  188

Asp Ile Val Met Thr Gln Ser Pro Asp Phe Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Ser Cys Lys Ser Ser Gln Ser Val Leu Tyr Thr 
            20                  25                  30          


Pro Lys Asn Lys Asn Tyr Leu Ala Trp Tyr Lys Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Val Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Ile 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Ala Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Thr Ala Pro Leu Thr Phe Gly Gly Gly Thr Arg Val Glu Ile 
            100                 105                 110         


<210>  189

<400>  189
000

<210>  190

<400>  190
000

<210>  191
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  191

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Ser Tyr 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Pro Asp Tyr Ser Ser Gly Trp Phe Ser Tyr Trp Tyr Phe Asp 
            100                 105                 110         


Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  192
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  192

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Phe Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Arg Ser Pro 
                85                  90                  95      


Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  193
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  193

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Leu Thr Glu Leu 
            20                  25                  30          


Ser Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Phe Asp Pro Glu Asp Ala Glu Thr Ile Tyr Ala Gln Gln Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Glu Asp Thr Ser Thr Asp Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Lys Ser Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Thr Gly Phe Ala Val Phe Gly Arg Ala Ala Val Pro Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  194
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  194

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Phe Gly Asp Lys Leu Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Phe Gln Gln Lys Pro Gly Gln Ser Pro Val Leu Ile Ile Tyr 
        35                  40                  45              


Gln Gly Ala Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Val Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  195
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  195

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Leu Thr Ile Val Val Ile Pro Ala Ala Pro Asn Phe Asp 
            100                 105                 110         


Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 


<210>  196
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  196

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Arg Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr Pro Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  197
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  197

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Ser His 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Ala Leu Arg Glu Arg Gly Val Gln Leu Trp Ser Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  198
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  198

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Phe Ile Asn Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser 
                85                  90                  95      


Leu Gly Ala Leu Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  199
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  199

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gln Glu Trp Phe Arg Glu Leu Phe Leu Phe Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  200
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  200

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ala Asn Ser Phe Pro Pro 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105         


<210>  201
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  201

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Gly Ser Ile Ala Ala Ala Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  202
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  202

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu His Ser 
            20                  25                  30          


Ser Asn Asn Lys Asp Ser Leu Val Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Ser Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Thr Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  203
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  203

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Asn Ser Asn Ser Phe Ile Tyr Tyr Ala Asp Ser Met 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Asn Gly Asn Ser Asn Trp Asn Phe Gly Ser Tyr Tyr Tyr 
            100                 105                 110         


Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  204
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  204

Glu Ile Val Leu Thr Gln Ser Pro Ala Ile Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Thr Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Phe Tyr Tyr Cys Gln Gln Arg Gly Asn Trp Trp Thr 
                85                  90                  95      


Phe Ala Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105     


<210>  205
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  205

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Lys Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Gly Tyr 
            20                  25                  30          


Ser Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ser Ile Ser Ser Ser Ser Ser Tyr Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Trp Leu Gln Leu Arg Ser Asp Tyr Tyr Tyr Phe Gly Met Asp 
            100                 105                 110         


Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210>  206
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  206

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Asn Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln His Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Phe Cys Gln Gln Cys Tyr Asn Trp Pro Pro 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  207
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  207

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Tyr Ile Tyr Tyr Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Met Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Arg Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ala Pro Arg Glu Arg Leu Gln Trp Gly Glu Tyr Tyr Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  208
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  208

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Ala Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Val Ile Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Val Ser 
                85                  90                  95      


Thr Thr Tyr Val Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  209
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  209

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Asn Ser 
            20                  25                  30          


Trp Ile Gly Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Thr His Arg Cys Ser Gly Gly Phe Cys Tyr Leu Ala Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  210
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  210

Gln Pro Val Leu Thr Gln Pro Pro Ser Ala Ser Ala Ser Leu Gly Ala 
1               5                   10                  15      


Ser Val Thr Leu Thr Cys Thr Leu Ser Ser Gly Tyr Ser Asn Tyr Lys 
            20                  25                  30          


Val Asp Trp Tyr Gln Gln Arg Pro Gly Lys Gly Pro Arg Phe Val Met 
        35                  40                  45              


Arg Val Gly Thr Gly Gly Ile Val Gly Ser Lys Gly Asp Gly Ile Pro 
    50                  55                  60                  


Asp Arg Phe Ser Val Leu Gly Ser Gly Leu Asn Arg Tyr Leu Thr Ile 
65                  70                  75                  80  


Lys Asn Ile Gln Glu Glu Asp Glu Ser Asp Tyr His Cys Gly Ala Asp 
                85                  90                  95      


His Gly Ser Gly Ser Asn Phe Val Phe Val Val Phe Gly Gly Gly Thr 
            100                 105                 110         


Lys Leu Thr Val Leu 
        115         


<210>  211
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  211

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp Tyr Asp Gly Ser Lys Lys Asp Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gln Ser Gln Gly Ala Tyr Ile Leu Thr Gly Tyr Arg Gly 
            100                 105                 110         


Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125             


<210>  212
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  212

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Asn Gly Tyr Asn Tyr Leu Asp Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Gln Phe Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Ile Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105                 110         


<210>  213
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  213

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Tyr Gly Gly Ser Phe Ser Gly His 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Pro Pro Gln Ala Ala Arg Ile His Tyr Tyr Tyr Tyr Met Asp Val 
            100                 105                 110         


Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  214
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  214

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Tyr Trp Pro Pro 
                85                  90                  95      


Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  215
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  215

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Asp Ser Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Arg Gly Ala Gly Tyr Thr Ser Tyr Met Asp Val Trp Gly 
            100                 105                 110         


Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  216
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  216

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Glu Gly Asn Asn Ile Gly Ser Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Gly Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Phe Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  217
<211>  99
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  217

Tyr Thr Thr Leu Phe Arg Ser Gly Gly His Trp Ile Gly Trp Val Arg 
1               5                   10                  15      


Gln Met Pro Gly Lys Gly Leu Glu Trp Met Gly Ile Ile Tyr Pro Gly 
            20                  25                  30          


Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe Gln Gly Gln Val Thr Ile 
        35                  40                  45              


Ser Ala Asp Lys Ser Ile Ser Thr Ala Tyr Leu Gln Trp Ser Ser Leu 
    50                  55                  60                  


Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys Ala Ser Ala Leu Arg Glu 
65                  70                  75                  80  


Arg Gly Val Gln Leu Trp Ser Val Trp Gly Gln Gly Thr Leu Val Thr 
                85                  90                  95      


Val Ser Ser 
            


<210>  218
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  218

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Phe Ile Asn Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser 
                85                  90                  95      


Leu Gly Ala Leu Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  219
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  219

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Ser Ile Ala Tyr Thr Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Ala His Ser Thr Gly His Gln Tyr Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120             


<210>  220
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  220

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Phe 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Phe Asn Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Asn Thr Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  221
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  221

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Ser Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Val Ser Ser Ile Thr Ser Leu Leu Gly Tyr Tyr Phe Asp Ser 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  222
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  222

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln His Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Arg Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  223
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  223

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Thr Ser Gly Asp Thr Ser Ser Ser Tyr 
            20                  25                  30          


Thr Val Gly Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Arg Ile Ile Pro Ile Leu Gly Ile Ala Tyr Ser Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Leu Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ser Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Val Val Ala Ala Thr Pro Gly Trp Phe Asp Pro Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  224
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  224

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Val Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Gly Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Phe Leu Thr 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105     


<210>  225
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  225

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met His Trp Val Arg Gln Val Pro Gly Lys Gly Leu Val Trp Val 
        35                  40                  45              


Ser Arg Ile Asn Ser Asp Gly Ser Ser Thr Ser Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Glu Met Asn Ser Leu Arg Ala Gln Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Gly Ser Pro Trp Leu Arg Gly Asp Ile Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  226
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  226

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Met Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Gly 
                85                  90                  95      


Ser Asn His Ala Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110         


<210>  227
<211>  130
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  227

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp Tyr 
            20                  25                  30          


Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Pro Asn Ser Arg Gly Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Arg Leu Thr Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Val Val Leu Gly Tyr Gly Arg Pro Asn Asn Tyr Tyr Asp 
            100                 105                 110         


Gly Arg Asn Val Trp Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val 
        115                 120                 125             


Ser Ser 
    130 


<210>  228
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  228

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Ile Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Ser Asn 
            20                  25                  30          


Thr Val Lys Trp Tyr His Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Cys Ser Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Asp Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Ala Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  229
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  229

Gln Val Thr Leu Arg Glu Ser Gly Pro Ala Leu Val Lys Pro Thr Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Phe Ser Gly Phe Ser Leu Gly Thr Ser 
            20                  25                  30          


Gly Met Cys Val Ser Trp Ile Arg Gln Pro Pro Gly Lys Ala Leu Glu 
        35                  40                  45              


Trp Leu Ala Arg Ile Asp Trp Asp Asp Asp Lys Tyr Tyr Ser Thr Ser 
    50                  55                  60                  


Leu Lys Thr Arg Leu Thr Ile Ser Lys Asp Thr Ser Lys Asn Gln Val 
65                  70                  75                  80  


Val Leu Thr Met Thr Asn Met Asp Pro Val Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Gly Val Val Thr Tyr Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Thr Val Ser Ser 
        115         


<210>  230
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  230

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ala Gly Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Gly Thr Thr Ser Leu Gln Ser Gly Val Pro Val Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Gly 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105         


<210>  231
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  231

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Asp Thr Phe Ser Ser Tyr 
            20                  25                  30          


Thr Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Arg Ile Ile Pro Ile Leu Gly Ile Pro Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Phe 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Arg Gly Tyr Ser Asn Tyr Gly Ala Ser Tyr Tyr Met Asp 
            100                 105                 110         


Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210>  232
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  232

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn His Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Thr Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Val Ala Thr Tyr Tyr Cys Gln Gln Ser Asp Asn Leu Pro Met 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  233
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  233

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Asp Ser Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Arg Gly Ala Gly Tyr Thr Ser Tyr Met Asp Val Trp Gly 
            100                 105                 110         


Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  234
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  234

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Glu Gly Asn Asn Ile Gly Ser Lys Ser Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Tyr 
        35                  40                  45              


Asp Asp Ser Gly Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Arg Val Glu Ala Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Phe Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


His Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  235

<400>  235
000

<210>  236

<400>  236
000

<210>  237
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  237

Gln Val Gln Leu Ala Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ala Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Ser Asn Ser Gly Asn Ala Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Thr Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Met Arg Thr Gly Trp Pro Thr His Gly Arg Pro Asp Asp Phe 
            100                 105                 110         


Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  238
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  238

Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Asn Ser Asn Ile Gly Ser Tyr 
            20                  25                  30          


Thr Val Asn Trp Tyr Gln Gln Phe Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Asp Asn Asn Gln Arg Thr Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asn Tyr Tyr Cys Leu Val Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  239
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  239

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Pro Gly Gly Ser Ala Phe Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg His Asn Ser Asn Asn Thr Leu Cys Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Thr Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Ser Tyr Asp Ile Leu Thr Gly Tyr Arg Asp Ala Phe Asp Ile Trp 
            100                 105                 110         


Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120         


<210>  240
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  240

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ser Gly 
            20                  25                  30          


Ser Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Thr Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Arg 
                85                  90                  95      


Leu Ser Gly Phe Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110         


<210>  241
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  241

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Leu Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Cys Val 
        35                  40                  45              


Ser Val Ile Tyr Ala Gly Gly Asn Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Gly Asp Gly Gly Tyr Tyr Ser Pro Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  242
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  242

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Val Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Met Gln Ser Gly Val Pro Ser Arg Phe Arg Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Leu 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Gln 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  243
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  243

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Ser Gly Gly Ser Phe Ser Ala Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Arg 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Val Gly Tyr Ser Gln Gly Tyr Tyr Tyr Tyr Tyr Met Asp Val Trp 
            100                 105                 110         


Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120         


<210>  244
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  244

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Ser Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Ser Cys Gln Gln Ser Tyr Thr Thr Leu Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  245

<400>  245
000

<210>  246

<400>  246
000

<210>  247
<211>  125
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  247

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ser Ile Thr Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Arg Ile Ile Pro Val Leu Gly Ile Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Asp Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Gly Val Ser Gly Phe Lys Ser Gly Ser Asn Trp Tyr Phe 
            100                 105                 110         


Asp Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125 


<210>  248
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  248

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Leu Ser Cys Thr Gly Ser Asn Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser 
                85                  90                  95      


Leu Ser Asp Ser Val Phe Gly Gly Gly Thr Lys Val Thr Val Leu 
            100                 105                 110     


<210>  249

<400>  249
000

<210>  250

<400>  250
000

<210>  251
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  251

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Asn Pro Gly Gly Gly Ser Thr Thr Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Ser Asp Thr Ser Thr Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Ala Ile Pro Pro Asn Ser Arg Ala Glu Ile Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  252
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  252

Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Val Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Cys Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Tyr Asn Trp Pro Leu 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  253
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  253

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Arg Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ile Phe Asp Asp Tyr 
            20                  25                  30          


Asp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Gly Gly Asn Thr Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr His Cys 
                85                  90                  95      


Ala Val Ile Met Ser Pro Ile Pro Arg Tyr Ser Gly Tyr Asp Trp Ala 
            100                 105                 110         


Gly Gly Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  254
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  254

Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Val Pro Ile Leu Val Ile Tyr 
        35                  40                  45              


Asp Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Ser Ser Gly Asn Ala 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  255
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  255

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Met Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asn Leu Gly Pro Tyr Cys Ser Gly Gly Thr Cys Tyr Ser Leu 
            100                 105                 110         


Val Gly Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  256
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  256

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Ala Asn Leu Pro Phe 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105         


<210>  257

<400>  257
000

<210>  258

<400>  258
000

<210>  259

<400>  259
000

<210>  260

<400>  260
000

<210>  261
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  261

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Trp Asn Ser Gly Thr Ile Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ile Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Ile Ile Arg Gln Gly Glu Asp Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  262
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  262

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Asn Ile Ala Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Glu Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Trp 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  263
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  263

Glu Val Gln Leu Leu Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ile Ser Thr Ser Gly Gly Ala Thr Tyr Asn Ala Asp Ser 
    50                  55                  60                  


Val Arg Gly Arg Phe Thr Thr Ser Arg Asp Asn Ser Lys Asn Ile Leu 
65                  70                  75                  80  


Tyr Leu Gln Met Asn Ser Leu Arg Gly Glu Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Val Lys Gly Leu Phe Asp Trp Phe Pro Leu Trp Gly Gln Gly Thr 
            100                 105                 110         


Met Val Thr Val Ser Ser 
        115             


<210>  264
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  264

Asp Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Ile Leu Ser Cys Arg Ala Ser Gln Ser Val Arg Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Ser Gly Ala Ser Thr Arg Ala Thr Ala Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Thr Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Cys Ala Val Tyr Tyr Cys His Gln Tyr Asn Asn Trp Pro Gln 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  265
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  265

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg His 
            20                  25                  30          


Trp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Ser Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Leu Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Gly Phe Tyr Tyr Gly Gly Ala Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  266
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  266

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Ser Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Gly 
                85                  90                  95      


Ile Asn Arg Ala Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110         


<210>  267
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  267

Asn Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe His His Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Gly Ile Ser Gly Ser Ser Asp Tyr Arg Ala Tyr Ala Asp Ser Leu 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Tyr Ala Lys Asn Ser Leu Trp 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Thr Ser Glu Asp Thr Ala Phe Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Val Asp Tyr Gly Gly Lys Leu Ala Tyr Phe Asp Ser Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  268
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  268

Asp Ile Val Met Thr Gln Ser Pro Leu Ser Leu Pro Val Thr Pro Gly 
1               5                   10                  15      


Glu Pro Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Leu His Ser 
            20                  25                  30          


Leu Gly Tyr Asn Ser Leu Ser Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro His Leu Leu Ile Tyr Leu Gly Ser Asn Arg Ala Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Ala Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Leu Glu Ala Glu Asp Val Gly Val Tyr Tyr Cys Met Gln Ala 
                85                  90                  95      


Leu Gln Thr Pro Leu Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105                 110         


<210>  269
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  269

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ser Phe Ser Ser Tyr 
            20                  25                  30          


Val Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Ser Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Ile Asp Ser Gly Tyr Asp Pro Thr Pro Val Phe Asp Tyr 
            100                 105                 110         


Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120             


<210>  270
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  270

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Cys Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Gly Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Ser Leu Ser 
                85                  90                  95      


Ile Thr Phe Gly Gln Gly Thr Arg Leu Glu Ile Lys 
            100                 105             


<210>  271
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  271

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Asp Leu His Trp Val Arg Gln Gly Thr Gly Lys Arg Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Gly Thr Ala Gly Asp Thr Tyr Tyr Leu Gly Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Glu Asn Ala Lys Asn Ser Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Gly Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Val Leu Tyr Asp Ser Ser Gly Phe Tyr Asn Trp Phe Asp Pro Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  272
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  272

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Glu Ile Pro Pro 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  273
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  273

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Val Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Leu Ile Tyr Ser Gly Gly Thr Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Phe Leu Arg Trp His Asp Leu Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210>  274
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  274

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Leu Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Ile Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Pro Pro 
                85                  90                  95      


Val Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  275
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  275

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Asp Thr Phe Ser Ser Tyr 
            20                  25                  30          


Thr Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Arg Ile Ile Pro Ile Leu Gly Ile Pro Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Phe 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Arg Gly Tyr Ser Asn Tyr Gly Ala Ser Tyr Tyr Met Asp 
            100                 105                 110         


Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210>  276
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  276

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Ala Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Tyr Asp Val His Trp Tyr Gln Gln Leu Pro Glu Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Ala Asn Ser Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser Ser 
                85                  90                  95      


Leu Ser Gly Ser Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  277
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  277

Gln Leu Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Ser 
            20                  25                  30          


Ser Tyr Tyr Trp Gly Trp Ile Arg Gln Pro Pro Gly Asn Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Gly Arg Val Ser Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Ile Leu Val Ile Phe Thr Leu Asn Trp Phe Asp Pro Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  278
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  278

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Ile Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Ser 
                85                  90                  95      


Gly Asn Pro Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  279

<400>  279
000

<210>  280

<400>  280
000

<210>  281
<211>  116
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  281

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Glu Val Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Leu Ile Tyr Ser Gly Gly Thr Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Asp Phe Leu Arg Trp His Asp Leu Trp Gly Gln Gly Thr Leu Val 
            100                 105                 110         


Thr Val Ser Ser 
        115     


<210>  282
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  282

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Asn Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Leu Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Pro Pro 
                85                  90                  95      


Val Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  283
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  283

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Val Ser Ser Gly 
            20                  25                  30          


Ser Tyr Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Cys Ile Gly Tyr Ile Tyr Tyr Ser Gly Ser Ser Asn Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Lys Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Met Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Gly Ser Pro Val Pro Pro Thr Ile Val Gly Ala Ser Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  284
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  284

Asn Phe Met Leu Thr Gln Pro His Ser Val Ser Glu Ser Pro Gly Lys 
1               5                   10                  15      


Thr Val Thr Phe Ser Cys Thr Gly Ser Ser Gly Ser Ile Ala Ser Asn 
            20                  25                  30          


Tyr Val Gln Trp Tyr Gln Gln Arg Pro Gly Ser Ala Pro Thr Thr Val 
        35                  40                  45              


Ile Tyr Glu Asp Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Ile Asp Ser Ser Ser Asn Ser Ala Ser Leu Thr Ile Ser Gly 
65                  70                  75                  80  


Leu Lys Thr Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Tyr Asp Gly 
                85                  90                  95      


Ile Asn Arg Trp Leu Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110         


<210>  285
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  285

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Glu 
1               5                   10                  15      


Ser Leu Lys Ile Ser Cys Lys Gly Ser Gly Tyr Ser Phe Thr Ser Tyr 
            20                  25                  30          


Trp Ile Asp Trp Val Arg Gln Met Pro Gly Lys Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Ile Ile Tyr Pro Gly Asp Ser Asp Thr Arg Tyr Ser Pro Ser Phe 
    50                  55                  60                  


Gln Gly Gln Val Thr Ile Ser Ala Asp Lys Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Leu Gln Trp Ser Ser Leu Lys Ala Ser Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Gly Glu Ala Ala Gly Ile Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  286
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  286

Gln Pro Val Leu Thr Gln Pro Pro Ser Ala Ser Ala Ser Leu Gly Ala 
1               5                   10                  15      


Ser Val Thr Leu Thr Cys Thr Leu Ser Ser Gly Tyr Ser Asn Tyr Lys 
            20                  25                  30          


Val Asp Trp Tyr Gln Gln Arg Pro Gly Lys Gly Pro Arg Phe Val Met 
        35                  40                  45              


Arg Val Gly Thr Gly Gly Ile Val Gly Ser Lys Gly Asp Gly Ile Pro 
    50                  55                  60                  


Asp Arg Phe Ser Val Leu Gly Ser Gly Leu Asn Arg Tyr Leu Thr Ile 
65                  70                  75                  80  


Lys Asn Ile Gln Glu Glu Asp Glu Ser Asp Tyr His Cys Gly Ala Asp 
                85                  90                  95      


His Gly Ser Gly Ser Asn Phe Glu Tyr Val Val Phe Gly Gly Gly Thr 
            100                 105                 110         


Lys Leu Thr Val Leu 
        115         


<210>  287
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  287

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Ser Ala Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Ser Ile Ser Arg Asp Lys Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Lys Glu Gly Gly Ser Gly Ser Leu Arg Tyr Tyr Tyr Tyr Gly Met Asp 
            100                 105                 110         


Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210>  288
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  288

Gln Ser Val Val Thr Gln Pro Pro Ser Ala Ser Gly Thr Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Ile Ser Cys Ser Gly Ser Ser Ser Asn Ile Gly Tyr Asn 
            20                  25                  30          


Ile Val Asn Trp Tyr Gln Gln Leu Pro Gly Thr Ala Pro Lys Leu Leu 
        35                  40                  45              


Ile Tyr Ser Asn Asn Gln Arg Pro Ser Gly Val Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Lys Ser Gly Thr Ser Ala Ser Leu Ser Ile Ser Gly Leu Gln 
65                  70                  75                  80  


Ser Glu Asp Glu Ala Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu 
                85                  90                  95      


Asn Gly Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110 


<210>  289
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  289

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Ile Gly Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Trp Ala Pro Thr Tyr Tyr Asp Met Pro Ser Ala Phe Asp 
            100                 105                 110         


Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 


<210>  290
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  290

Ser Tyr Val Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Asn Lys Gly Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Asp 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Ile Ile Ser Ser Val Glu Val Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Phe Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


Pro Gly Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  291
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  291

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Glu Ala Ser Gly Phe Thr Phe Ser Ser Ser 
            20                  25                  30          


Glu Ile Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser His Ile Ser Ser Ser Gly Ser Ile Ile Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Arg Ser Tyr Arg Ser Ser Trp Tyr Tyr Tyr Tyr Gly Met Asp 
            100                 105                 110         


Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 


<210>  292
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  292

Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Leu Asn Ser Tyr Pro Val 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  293
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  293

Gln Val Gln Leu Ala Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Thr Ser Gly Ser Tyr Tyr Tyr Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  294
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  294

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Asp Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Glu Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr Leu Leu Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110         


<210>  295
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  295

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Arg Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Val Phe Gly Thr Ala Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Lys Ser Thr Ser Thr Ala Phe 
65                  70                  75                  80  


Met Glu Leu Asn Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Gly Ser Tyr Pro Glu Tyr Phe Gln His Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  296
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  296

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Phe 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys His Tyr Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Val Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile 
            100                 105             


<210>  297
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  297

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ile Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Val Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Gly His Phe Asp Ser Ser Gly Tyr Tyr Leu Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  298
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  298

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Phe 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Pro Thr Gly Ile Pro Ala Arg Phe Thr Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln His Arg Thr Asn Trp Pro Pro 
                85                  90                  95      


Leu Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105                 


<210>  299
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  299

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Leu Phe Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Asn Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Pro Tyr Thr Gly Ser Tyr Lys Ser Tyr Met Asp Val Trp Gly 
            100                 105                 110         


Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  300
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  300

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Asn Ser Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Ile Ser Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  301
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  301

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Gln 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Gly 
            20                  25                  30          


Gly Tyr Phe Trp Ser Trp Ile Arg Gln His Pro Gly Lys Gly Leu Glu 
        35                  40                  45              


Trp Ile Gly Ser Ile Tyr Tyr Ser Gly Ser Thr Tyr Tyr Asn Pro Ser 
    50                  55                  60                  


Leu Arg Ser Arg Ile Thr Ile Ser Val Asp Thr Ser Lys Asn Gln Phe 
65                  70                  75                  80  


Ser Leu Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr 
                85                  90                  95      


Cys Ala Arg Gly Gly Ser Gly Ser Tyr Ser Leu Phe Asp Tyr Trp Gly 
            100                 105                 110         


Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  302
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  302

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Thr Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Asn Leu Tyr Ser 
                85                  90                  95      


Val His Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  303
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  303

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Arg His 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ala Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Pro Ser Pro Leu Val Leu Ile Thr Ser Ile Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  304
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  304

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Ser Gly Asp Ala Leu Pro Arg Gln Tyr Thr 
            20                  25                  30          


Tyr Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Lys Asp Ser Glu Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Thr Thr Val Thr Leu Thr Ile Ser Gly Val Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Ala Asp Thr Ile Gly Thr Tyr 
                85                  90                  95      


Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  305
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  305

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Trp Met Thr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Ser Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Ser 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Val Arg Leu Gly Val Ser Ser Trp Tyr Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  306
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  306

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Gln Asp Thr Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Gly Ser Ser Arg Gly Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  307
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  307

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Ala Ala Asn Tyr Ala Gln Asn Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Gly Tyr 
65                  70                  75                  80  


Met Gln Leu Ser Ser Leu Arg Phe Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Thr Ser His Tyr Asp Ser Ser Gly Ser Tyr Phe Glu Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  308
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  308

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Asp Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys His Lys Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Ser Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile 
            100                 105             


<210>  309

<400>  309
000

<210>  310

<400>  310
000

<210>  311

<400>  311
000

<210>  312
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  312

Gly Phe Thr Phe Ser Phe Tyr Trp 
1               5               


<210>  313
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  313

Ile Lys Gln Asp Gly Gly Glu Lys 
1               5               


<210>  314
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  314

Ala Arg Leu Ser Gly Ser Ser Trp Asp Phe Asp Tyr 
1               5                   10          


<210>  315
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  315

Gly Phe Thr Phe Asp Asp Tyr Gly 
1               5               


<210>  316
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  316

Ile Asn Trp Asn Gly Gly Ser Thr 
1               5               


<210>  317
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  317

Ala Arg Arg Arg Ser Ser Ser Arg Tyr Ser Ser Gly Trp Tyr Met Tyr 
1               5                   10                  15      


Tyr Tyr Tyr Met Asp Val 
            20          


<210>  318
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  318

Gly Phe Ser Val Ser Thr Ser Gly Glu Gly 
1               5                   10  


<210>  319
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  319

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  320
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  320

Ala His Arg Leu Trp Phe Arg Asp Ala Phe Asp Ile 
1               5                   10          


<210>  321
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  321

Gly Phe Thr Phe Ser Thr Tyr Trp 
1               5               


<210>  322
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  322

Ile Lys Gln Asp Gly Ser Glu Lys 
1               5               


<210>  323
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  323

Ala Arg Val Gly Ser Ser Ser Trp Tyr Phe Asp Tyr 
1               5                   10          


<210>  324
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  324

Gly Gly Ser Ile Ser Ser Gly Thr Tyr Tyr 
1               5                   10  


<210>  325
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  325

Thr Tyr Tyr Gly Gly Ser Thr 
1               5           


<210>  326
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  326

Ala Arg Arg Gly Asn Tyr Tyr Asp Ser Lys Asn Trp Phe Asp Pro 
1               5                   10                  15  


<210>  327
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  327

Gly Phe Thr Phe Ser Ser His Gly 
1               5               


<210>  328
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  328

Ile Trp Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  329
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  329

Ala Arg Glu Ser Ala Asp Ile Ser Ser Arg Leu Asp Tyr 
1               5                   10              


<210>  330
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  330

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  331
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  331

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  332
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  332

Ala Arg Ala Asp Thr Met Val Arg Gly Thr Tyr Phe Glu Tyr 
1               5                   10                  


<210>  333
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  333

Gly Phe Ser Leu Ser Thr Ser Gly Val Gly 
1               5                   10  


<210>  334
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  334

Ile Tyr Trp Asp Asp Asp Lys 
1               5           


<210>  335
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  335

Ala His Arg Leu Pro Thr Pro Gln Leu Leu Pro Ser Phe Glu Asn Trp 
1               5                   10                  15      


Phe Asp Pro 
            


<210>  336
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  336

Gly Phe Thr Phe Ser Ser Tyr Trp 
1               5               


<210>  337
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  337

Ile Asn Ser Asp Gly Ser Ser Thr 
1               5               


<210>  338
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  338

Ala Arg Glu Val Glu Gln Leu Ala His Met Val Asp Tyr 
1               5                   10              


<210>  339
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  339

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  340
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  340

Ile Ser Tyr Asp Gly Ile Asn Lys 
1               5               


<210>  341
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  341

Ala Arg Pro Arg Ser Gly Ser Tyr Tyr Ala Tyr Phe Asp Tyr 
1               5                   10                  


<210>  342
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  342

Gly Phe Thr Phe Ser Tyr Tyr Pro 
1               5               


<210>  343
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  343

Thr Ser Tyr Asp Gly Thr Asn Lys 
1               5               


<210>  344
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  344

Ala Arg Gly Gly Ala Thr Asn Phe Asp Tyr 
1               5                   10  


<210>  345
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  345

Gly Phe Thr Phe Asp Asp Ser Ala 
1               5               


<210>  346
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  346

Ile Ser Trp Asn Ser Gly Asn Val 
1               5               


<210>  347
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  347

Thr Lys Ala Ser Arg Tyr Cys Ser Ser Thr Ile Cys Tyr Trp Asn Trp 
1               5                   10                  15      


Phe Asp Pro 
            


<210>  348
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  348

Gly Phe Thr Phe Ser Ser Tyr Glu 
1               5               


<210>  349
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  349

Ile Ser Ser Ser Gly Ser Ala Ile 
1               5               


<210>  350
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  350

Ala Arg Glu Ala Arg Ser Arg Tyr Phe Asp Trp Leu Pro Ser Tyr Tyr 
1               5                   10                  15      


Phe Asp Tyr 
            


<210>  351
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  351

Gly Tyr Thr Phe Thr Thr Tyr Ala 
1               5               


<210>  352
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  352

Ile Asn Thr Asn Thr Gly Asn Pro 
1               5               


<210>  353
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  353

Ala Arg Asp Gln Asp Ser Gly Tyr Pro Thr Tyr Tyr Tyr Tyr Tyr Met 
1               5                   10                  15      


Asp Val 
        


<210>  354
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  354

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  355
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  355

Ile Ser Tyr Asp Gly Tyr Asn Lys 
1               5               


<210>  356
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  356

Ala Arg Gly Ser Ala Gly Asn Tyr Tyr Tyr Gly Met Asp Val 
1               5                   10                  


<210>  357
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  357

Gly Phe Thr Phe Ser Asn Tyr Gly 
1               5               


<210>  358
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  358

Ile Ser Asn Asp Glu Phe Asn Lys 
1               5               


<210>  359
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  359

Ala Lys Gly Gly Asp Gly Ser Gly Trp Ala Trp Asp Gly Asp Asn Pro 
1               5                   10                  15      


Pro Thr Asp Tyr 
            20  


<210>  360

<400>  360
000

<210>  361

<400>  361
000

<210>  362

<400>  362
000

<210>  363
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  363

Gly Tyr Ser Phe Thr Ser Tyr Trp 
1               5               


<210>  364
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  364

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  365
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  365

Ala Arg Pro Asp Tyr Ser Ser Gly Trp Phe Ser Tyr Trp Tyr Phe Asp 
1               5                   10                  15      


Leu 
    


<210>  366
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  366

Gly Tyr Thr Leu Thr Glu Leu Ser 
1               5               


<210>  367
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  367

Phe Asp Pro Glu Asp Ala Glu Thr 
1               5               


<210>  368
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  368

Ala Thr Gly Phe Ala Val Phe Gly Arg Ala Ala Val Pro Tyr 
1               5                   10                  


<210>  369
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  369

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  370
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  370

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  371
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  371

Ala Lys Asp Leu Thr Ile Val Val Ile Pro Ala Ala Pro Asn Phe Asp 
1               5                   10                  15      


Tyr 
    


<210>  372
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  372

Gly Tyr Ser Phe Thr Ser His Trp 
1               5               


<210>  373
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  373

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  374
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  374

Ala Ser Ala Leu Arg Glu Arg Gly Val Gln Leu Trp Ser Val 
1               5                   10                  


<210>  375
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  375

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  376
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  376

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  377
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  377

Ala Arg Asp Gln Glu Trp Phe Arg Glu Leu Phe Leu Phe Asp Tyr 
1               5                   10                  15  


<210>  378
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  378

Gly Phe Thr Phe Ser Thr Tyr Gly 
1               5               


<210>  379
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  379

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  380
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  380

Ala Lys Asp Gly Ser Ile Ala Ala Ala Asp Tyr 
1               5                   10      


<210>  381
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  381

Gly Phe Thr Phe Ser Ser Tyr Ser 
1               5               


<210>  382
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  382

Ile Ser Asn Ser Asn Ser Phe Ile 
1               5               


<210>  383
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  383

Ala Arg Val Asn Gly Asn Ser Asn Trp Asn Phe Gly Ser Tyr Tyr Tyr 
1               5                   10                  15      


Tyr Tyr Met Asp Val 
            20      


<210>  384
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  384

Gly Phe Thr Phe Ser Gly Tyr Ser 
1               5               


<210>  385
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  385

Ile Ser Ser Ser Ser Ser Tyr Ile 
1               5               


<210>  386
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  386

Ala Arg Trp Leu Gln Leu Arg Ser Asp Tyr Tyr Tyr Phe Gly Met Asp 
1               5                   10                  15      


Val 
    


<210>  387
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  387

Gly Gly Ser Ile Ser Ser Tyr Tyr 
1               5               


<210>  388
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  388

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  389
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  389

Ala Arg Ala Pro Arg Glu Arg Leu Gln Trp Gly Glu Tyr Tyr Phe Asp 
1               5                   10                  15      


Tyr 
    


<210>  390
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  390

Gly Tyr Ser Phe Thr Asn Ser Trp 
1               5               


<210>  391
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  391

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  392
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  392

Ala Thr His Arg Cys Ser Gly Gly Phe Cys Tyr Leu Ala Tyr 
1               5                   10                  


<210>  393
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  393

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  394
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  394

Ile Trp Tyr Asp Gly Ser Lys Lys 
1               5               


<210>  395
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  395

Ala Arg Asp Gln Ser Gln Gly Ala Tyr Ile Leu Thr Gly Tyr Arg Gly 
1               5                   10                  15      


Tyr Gly Met Asp Val 
            20      


<210>  396
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  396

Gly Gly Ser Phe Ser Gly His Tyr 
1               5               


<210>  397
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  397

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  398
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  398

Ala Arg Pro Pro Gln Ala Ala Arg Ile His Tyr Tyr Tyr Tyr Met Asp 
1               5                   10                  15      


Val 
    


<210>  399
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  399

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  400
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  400

Ile Ser Trp Asn Ser Asp Ser Ile 
1               5               


<210>  401
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  401

Ala Lys Gly Arg Gly Ala Gly Tyr Thr Ser Tyr Met Asp Val 
1               5                   10                  


<210>  402
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  402

Leu Phe Arg Ser Gly Gly His Trp 
1               5               


<210>  403
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  403

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  404
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  404

Ala Ser Ala Leu Arg Glu Arg Gly Val Gln Leu Trp Ser Val 
1               5                   10                  


<210>  405
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  405

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  406
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  406

Ile Ser Trp Asn Ser Gly Ser Ile 
1               5               


<210>  407
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  407

Ala Lys Ala His Ser Thr Gly His Gln Tyr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  408
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  408

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  409
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  409

Ile Ser Trp Asn Ser Gly Ser Ile 
1               5               


<210>  410
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  410

Ala Lys Val Ser Ser Ile Thr Ser Leu Leu Gly Tyr Tyr Phe Asp Ser 
1               5                   10                  15      


<210>  411
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  411

Gly Asp Thr Ser Ser Ser Tyr Thr 
1               5               


<210>  412
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  412

Ile Ile Pro Ile Leu Gly Ile Ala 
1               5               


<210>  413
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  413

Ala Arg Gly Val Val Ala Ala Thr Pro Gly Trp Phe Asp Pro 
1               5                   10                  


<210>  414
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  414

Gly Phe Thr Phe Ser Ser Tyr Trp 
1               5               


<210>  415
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  415

Ile Asn Ser Asp Gly Ser Ser Thr 
1               5               


<210>  416
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  416

Ala Gly Ser Pro Trp Leu Arg Gly Asp Ile Asp Tyr 
1               5                   10          


<210>  417
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  417

Gly Tyr Thr Phe Thr Asp Tyr Tyr 
1               5               


<210>  418
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  418

Ile Asn Pro Asn Ser Arg Gly Thr 
1               5               


<210>  419
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  419

Ala Arg Val Val Val Leu Gly Tyr Gly Arg Pro Asn Asn Tyr Tyr Asp 
1               5                   10                  15      


Gly Arg Asn Val Trp Asp Tyr 
            20              


<210>  420
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  420

Gly Phe Ser Leu Gly Thr Ser Gly Met Cys 
1               5                   10  


<210>  421
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  421

Ile Asp Trp Asp Asp Asp Lys 
1               5           


<210>  422
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  422

Ala Arg Gly Val Val Thr Tyr Asp Tyr 
1               5                   


<210>  423
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  423

Gly Asp Thr Phe Ser Ser Tyr Thr 
1               5               


<210>  424
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  424

Ile Ile Pro Ile Leu Gly Ile Pro 
1               5               


<210>  425
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  425

Ala Arg Gly Arg Gly Tyr Ser Asn Tyr Gly Ala Ser Tyr Tyr Met Asp 
1               5                   10                  15      


Val 
    


<210>  426
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  426

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  427
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  427

Ile Ser Trp Asn Ser Asp Ser Ile 
1               5               


<210>  428
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  428

Ala Lys Gly Arg Gly Ala Gly Tyr Thr Ser Tyr Met Asp Val 
1               5                   10                  


<210>  429

<400>  429
000

<210>  430

<400>  430
000

<210>  431

<400>  431
000

<210>  432
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  432

Gly Tyr Thr Phe Thr Ser Tyr Asp 
1               5               


<210>  433
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  433

Met Asn Ser Asn Ser Gly Asn Ala 
1               5               


<210>  434
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  434

Ala Arg Met Arg Thr Gly Trp Pro Thr His Gly Arg Pro Asp Asp Phe 
1               5                   10                  15      


<210>  435
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  435

Gly Phe Thr Val Ser Ser Asn Tyr 
1               5               


<210>  436
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  436

Ile Tyr Pro Gly Gly Ser Ala 
1               5           


<210>  437
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  437

Ala Arg Ser Tyr Asp Ile Leu Thr Gly Tyr Arg Asp Ala Phe Asp Ile 
1               5                   10                  15      


<210>  438
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  438

Gly Leu Thr Val Ser Ser Asn Tyr 
1               5               


<210>  439
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  439

Ile Tyr Ala Gly Gly Asn Thr 
1               5           


<210>  440
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  440

Ala Arg Gly Asp Gly Gly Tyr Tyr Ser Pro Phe Asp Tyr 
1               5                   10              


<210>  441
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  441

Gly Gly Ser Phe Ser Ala Tyr Tyr 
1               5               


<210>  442
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  442

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  443
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  443

Ala Arg Val Gly Tyr Ser Gln Gly Tyr Tyr Tyr Tyr Tyr Met Asp Val 
1               5                   10                  15      


<210>  444

<400>  444
000

<210>  445

<400>  445
000

<210>  446

<400>  446
000

<210>  447
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  447

Gly Gly Thr Phe Ser Ser Tyr Ser 
1               5               


<210>  448
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  448

Ile Ile Pro Val Leu Gly Ile Ala 
1               5               


<210>  449
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  449

Ala Arg Val Gly Val Ser Gly Phe Lys Ser Gly Ser Asn Trp Tyr Phe 
1               5                   10                  15      


Asp Leu 
        


<210>  450

<400>  450
000

<210>  451

<400>  451
000

<210>  452

<400>  452
000

<210>  453
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  453

Gly Tyr Thr Phe Thr Ser Tyr Tyr 
1               5               


<210>  454
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  454

Ile Asn Pro Gly Gly Gly Ser Thr 
1               5               


<210>  455
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  455

Ala Arg Gly Ala Ile Pro Pro Asn Ser Arg Ala Glu Ile Asp Tyr 
1               5                   10                  15  


<210>  456
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  456

Gly Phe Ile Phe Asp Asp Tyr Asp 
1               5               


<210>  457
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  457

Ile Ser Trp Asn Gly Gly Asn Thr 
1               5               


<210>  458
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  458

Ala Val Ile Met Ser Pro Ile Pro Arg Tyr Ser Gly Tyr Asp Trp Ala 
1               5                   10                  15      


Gly Gly Ala Phe Asp Ile 
            20          


<210>  459
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  459

Gly Phe Thr Phe Ser Asn Tyr Gly 
1               5               


<210>  460
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  460

Met Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  461
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  461

Ala Lys Asn Leu Gly Pro Tyr Cys Ser Gly Gly Thr Cys Tyr Ser Leu 
1               5                   10                  15      


Val Gly Asp Tyr 
            20  


<210>  462

<400>  462
000

<210>  463

<400>  463
000

<210>  464

<400>  464
000

<210>  465

<400>  465
000

<210>  466

<400>  466
000

<210>  467

<400>  467
000

<210>  468
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  468

Gly Phe Thr Phe Asp Asp Tyr Ala 
1               5               


<210>  469
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  469

Ile Ser Trp Asn Ser Gly Thr Ile 
1               5               


<210>  470
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  470

Ala Lys Asp Ile Ile Arg Gln Gly Glu Asp Gly Met Asp Val 
1               5                   10                  


<210>  471
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  471

Gly Phe Thr Phe Ser Asn Tyr Ala 
1               5               


<210>  472
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  472

Ile Ile Ser Thr Ser Gly Gly Ala Thr 
1               5                   


<210>  473
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  473

Val Lys Gly Leu Phe Asp Trp Phe Pro Leu 
1               5                   10  


<210>  474
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  474

Gly Phe Thr Phe Ser Arg His Trp 
1               5               


<210>  475
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  475

Ile Lys Gln Asp Gly Ser Glu Lys 
1               5               


<210>  476
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  476

Ala Arg Leu Gly Phe Tyr Tyr Gly Gly Ala Asp Tyr 
1               5                   10          


<210>  477
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  477

Gly Phe Thr Phe His His Tyr Ala 
1               5               


<210>  478
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  478

Ile Ser Gly Ser Ser Asp Tyr Arg 
1               5               


<210>  479
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  479

Ala Lys Gly Val Asp Tyr Gly Gly Lys Leu Ala Tyr Phe Asp Ser 
1               5                   10                  15  


<210>  480
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  480

Gly Phe Ser Phe Ser Ser Tyr Val 
1               5               


<210>  481
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  481

Ile Ser Tyr Asp Gly Ser Ser Lys 
1               5               


<210>  482
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  482

Ala Arg Asp Ile Asp Ser Gly Tyr Asp Pro Thr Pro Val Phe Asp Tyr 
1               5                   10                  15      


<210>  483
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  483

Gly Phe Thr Phe Ser Ser Tyr Asp 
1               5               


<210>  484
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  484

Ile Gly Thr Ala Gly Asp Thr 
1               5           


<210>  485
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  485

Ala Arg Val Leu Tyr Asp Ser Ser Gly Phe Tyr Asn Trp Phe Asp Pro 
1               5                   10                  15      


<210>  486
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  486

Glu Val Thr Val Ser Ser Asn Tyr 
1               5               


<210>  487
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  487

Ile Tyr Ser Gly Gly Thr Thr 
1               5           


<210>  488
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  488

Ala Arg Asp Phe Leu Arg Trp His Asp Leu 
1               5                   10  


<210>  489
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  489

Gly Asp Thr Phe Ser Ser Tyr Thr 
1               5               


<210>  490
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  490

Ile Ile Pro Ile Leu Gly Ile Pro 
1               5               


<210>  491
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  491

Ala Arg Gly Arg Gly Tyr Ser Asn Tyr Gly Ala Ser Tyr Tyr Met Asp 
1               5                   10                  15      


Val 
    


<210>  492
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  492

Gly Gly Ser Ile Ser Ser Ser Ser Tyr Tyr 
1               5                   10  


<210>  493
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  493

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  494
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  494

Ala Arg Ile Leu Val Ile Phe Thr Leu Asn Trp Phe Asp Pro 
1               5                   10                  


<210>  495

<400>  495
000

<210>  496

<400>  496
000

<210>  497

<400>  497
000

<210>  498
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  498

Glu Val Thr Val Ser Ser Asn Tyr 
1               5               


<210>  499
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  499

Ile Tyr Ser Gly Gly Thr Thr 
1               5           


<210>  500
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  500

Ala Arg Asp Phe Leu Arg Trp His Asp Leu 
1               5                   10  


<210>  501
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  501

Gly Gly Ser Val Ser Ser Gly Ser Tyr Tyr 
1               5                   10  


<210>  502
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  502

Ile Tyr Tyr Ser Gly Ser Ser 
1               5           


<210>  503
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  503

Ala Gly Ser Pro Val Pro Pro Thr Ile Val Gly Ala Ser Tyr 
1               5                   10                  


<210>  504
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  504

Gly Tyr Ser Phe Thr Ser Tyr Trp 
1               5               


<210>  505
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  505

Ile Tyr Pro Gly Asp Ser Asp Thr 
1               5               


<210>  506
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  506

Ala Arg Arg Gly Glu Ala Ala Gly Ile Trp Tyr Phe Asp Leu 
1               5                   10                  


<210>  507
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  507

Gly Phe Thr Val Ser Ser Asn Tyr 
1               5               


<210>  508
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  508

Ile Tyr Ser Ala Gly Ser Thr 
1               5           


<210>  509
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  509

Ala Lys Glu Gly Gly Ser Gly Ser Leu Arg Tyr Tyr Tyr Tyr Gly Met 
1               5                   10                  15      


Asp Val 
        


<210>  510
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  510

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  511
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  511

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  512
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  512

Ala Arg Asp Trp Ala Pro Thr Tyr Tyr Asp Met Pro Ser Ala Phe Asp 
1               5                   10                  15      


Ile 
    


<210>  513
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  513

Gly Phe Thr Phe Ser Ser Ser Glu 
1               5               


<210>  514
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  514

Ile Ser Ser Ser Gly Ser Ile Ile 
1               5               


<210>  515
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  515

Ala Arg Arg Ser Tyr Arg Ser Ser Trp Tyr Tyr Tyr Tyr Gly Met Asp 
1               5                   10                  15      


Val 
    


<210>  516
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  516

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  517
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  517

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  518
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  518

Ala Arg Ser Thr Ser Gly Ser Tyr Tyr Tyr Gly Met Asp Val 
1               5                   10                  


<210>  519
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  519

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  520
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  520

Ile Ile Pro Val Phe Gly Thr Ala 
1               5               


<210>  521
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  521

Ala Arg Ile Gly Ser Tyr Pro Glu Tyr Phe Gln His 
1               5                   10          


<210>  522
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  522

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  523
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  523

Ile Ile Pro Ile Phe Gly Thr Thr 
1               5               


<210>  524
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  524

Ala Arg Ile Gly His Phe Asp Ser Ser Gly Tyr Tyr Leu Asp Tyr 
1               5                   10                  15  


<210>  525
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  525

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  526
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  526

Ile Ser Tyr Asp Gly Asn Asn Lys 
1               5               


<210>  527
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  527

Ala Arg Pro Tyr Thr Gly Ser Tyr Lys Ser Tyr Met Asp Val 
1               5                   10                  


<210>  528
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  528

Gly Gly Ser Ile Ser Ser Gly Gly Tyr Phe 
1               5                   10  


<210>  529
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  529

Ile Tyr Tyr Ser Gly Ser Thr 
1               5           


<210>  530
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  530

Ala Arg Gly Gly Ser Gly Ser Tyr Ser Leu Phe Asp Tyr 
1               5                   10              


<210>  531
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  531

Gly Phe Thr Phe Ser Arg His Ala 
1               5               


<210>  532
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  532

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  533
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  533

Ala Arg Asp Pro Ser Pro Leu Val Leu Ile Thr Ser Ile Asp Tyr 
1               5                   10                  15  


<210>  534
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  534

Gly Phe Thr Phe Ser Ser Tyr Trp 
1               5               


<210>  535
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  535

Ile Lys Gln Asp Gly Ser Glu Lys 
1               5               


<210>  536
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  536

Val Arg Leu Gly Val Ser Ser Trp Tyr Phe Asp Tyr 
1               5                   10          


<210>  537
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  537

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  538
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  538

Ile Ile Pro Ile Phe Gly Ala Ala 
1               5               


<210>  539
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  539

Ala Arg Thr Ser His Tyr Asp Ser Ser Gly Ser Tyr Phe Glu Tyr 
1               5                   10                  15  


<210>  540
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  540

Gln Ser Val Ser Ser Tyr 
1               5       


<210>  541

<400>  541
000

<210>  542

<400>  542
000

<210>  543
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  543

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  544
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  544

Gln Asp Ser 
1           


<210>  545
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  545

Gln Ala Trp Asp Ser Ser Thr Gly Val 
1               5                   


<210>  546
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  546

Gln Ser Val Ser Thr Trp 
1               5       


<210>  547
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  547

Glu Ala Ser 
1           


<210>  548
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  548

Gln Gln Tyr Asn Thr Tyr Ser Gly Thr 
1               5                   


<210>  549
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  549

Gln Ser Ile Ser Asn Tyr 
1               5       


<210>  550
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  550

Ala Ala Ser 
1           


<210>  551
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  551

Gln Gln Thr Tyr Ser Thr Phe Trp Thr 
1               5                   


<210>  552
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  552

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  553
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  553

Gln Asp Ser 
1           


<210>  554
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  554

Gln Ala Trp Asp Ser Ser Thr Ala Val 
1               5                   


<210>  555
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  555

Gln Ser Val Ser Ser Asn 
1               5       


<210>  556
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  556

Gly Ala Ser 
1           


<210>  557
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  557

Gln Gln Tyr Asn Asn Trp Pro Pro Met Tyr Thr 
1               5                   10      


<210>  558
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  558

Ala Leu Pro Thr Lys Tyr 
1               5       


<210>  559
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  559

Asp Asp Ser 
1           


<210>  560
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  560

Tyr Ser Thr Asp Ser Ser Gly Asn Val 
1               5                   


<210>  561
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  561

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  562
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  562

Asp Val Ser 
1           


<210>  563
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  563

Ser Ser Tyr Thr Ser Ser Arg Ala Val Leu 
1               5                   10  


<210>  564
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  564

Ser Ser Asn Ile Gly Asn Asn Ala 
1               5               


<210>  565
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  565

Tyr Asp Asp 
1           


<210>  566
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  566

Ala Ser Trp Asp Asp Ser Leu Ile Gly Pro Val 
1               5                   10      


<210>  567
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  567

Ala Leu Pro Asn Gln Tyr 
1               5       


<210>  568
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  568

Lys Asp Ser 
1           


<210>  569
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  569

Gln Ser Ala Asp Ser Ser Gly Thr Ser Trp Val 
1               5                   10      


<210>  570
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  570

Gln Gly Ile Ser Asn Tyr 
1               5       


<210>  571
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  571

Ala Ala Ser 
1           


<210>  572
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  572

Gln Gln Tyr Asn Ser His Pro Pro Thr 
1               5                   


<210>  573
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  573

Asn Ile Gly Arg Lys Ser 
1               5       


<210>  574
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  574

Asp Asp Ser 
1           


<210>  575
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  575

Gln Val Trp Asp Ser Ser Ser Asp His Pro Glu Trp Val 
1               5                   10              


<210>  576
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  576

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  577
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  577

Gly Ala Ser 
1           


<210>  578
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  578

Gln Gln Ser Tyr Ser Thr Pro Thr 
1               5               


<210>  579
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  579

Ser Ser Asp Ile Gly Gly Tyr Asn Tyr 
1               5                   


<210>  580
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  580

Asp Val Ser 
1           


<210>  581
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  581

Ser Ser Tyr Thr Ser Ser Ser Thr His Val Val 
1               5                   10      


<210>  582
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  582

Gln Ser Leu Leu His Ser Asp Gly Lys Thr Tyr 
1               5                   10      


<210>  583
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  583

Glu Val Ser 
1           


<210>  584
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  584

Met Gln Ser Ile Gln Pro Pro Leu Thr 
1               5                   


<210>  585
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  585

Gln Thr Ile Thr Asn Tyr 
1               5       


<210>  586
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  586

Ala Ala Ser 
1           


<210>  587
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  587

Gln Gln Ser Tyr Ser Thr Pro Tyr Thr 
1               5                   


<210>  588
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  588

Gln Ser Val Leu Tyr Thr Pro Lys Asn Lys Asn Tyr 
1               5                   10          


<210>  589
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  589

Trp Ala Ser 
1           


<210>  590
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  590

Gln Gln Tyr Tyr Thr Ala Pro Leu Thr 
1               5                   


<210>  591

<400>  591
000

<210>  592

<400>  592
000

<210>  593

<400>  593
000

<210>  594
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  594

Gln Ser Val Ser Ser Asn Phe 
1               5           


<210>  595
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  595

Gly Ala Ser 
1           


<210>  596
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  596

Gln Gln Tyr Gly Arg Ser Pro Ile Thr 
1               5                   


<210>  597
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  597

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  598
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  598

Gln Gly Ala 
1           


<210>  599
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  599

Gln Ala Trp Asp Ser Ser Thr Val Val 
1               5                   


<210>  600
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  600

Ser Ser Asp Val Gly Gly Tyr Asn Tyr 
1               5                   


<210>  601
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  601

Asp Val Ser 
1           


<210>  602
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  602

Ser Ser Tyr Thr Ser Ser Ser Thr Pro Val Val 
1               5                   10      


<210>  603
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  603

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  604
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  604

Ile Asn Ser 
1           


<210>  605
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  605

Gln Ser Tyr Asp Ser Ser Leu Gly Ala Leu 
1               5                   10  


<210>  606
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  606

Gln Gly Ile Ser Ser Trp 
1               5       


<210>  607
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  607

Asp Ala Ser 
1           


<210>  608
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  608

Gln Gln Ala Asn Ser Phe Pro Pro Thr 
1               5                   


<210>  609
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  609

Gln Ser Val Leu His Ser Ser Asn Asn Lys Asp Ser 
1               5                   10          


<210>  610
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  610

Trp Ala Ser 
1           


<210>  611
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  611

Gln Gln Tyr Tyr Ser Thr Pro Trp Thr 
1               5                   


<210>  612
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  612

Gln Ser Val Ser Ser Tyr 
1               5       


<210>  613
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  613

Asp Thr Ser 
1           


<210>  614
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  614

Gln Gln Arg Gly Asn Trp Trp Thr 
1               5               


<210>  615
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  615

Gln Ser Val Ser Asn Asn 
1               5       


<210>  616
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  616

Gly Ala Ser 
1           


<210>  617
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  617

Gln Gln Cys Tyr Asn Trp Pro Pro Trp Thr 
1               5                   10  


<210>  618
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  618

Ser Ser Asp Val Gly Ser Tyr Asn Leu 
1               5                   


<210>  619
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  619

Glu Val Ile 
1           


<210>  620
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  620

Cys Ser Tyr Ala Val Ser Thr Thr Tyr Val Ile 
1               5                   10      


<210>  621
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  621

Ser Gly Tyr Ser Asn Tyr Lys 
1               5           


<210>  622
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  622

Val Gly Thr Gly Gly Ile Val Gly 
1               5               


<210>  623
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  623

Gly Ala Asp His Gly Ser Gly Ser Asn Phe Val Phe Val Val 
1               5                   10                  


<210>  624
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  624

Gln Ser Leu Leu His Ser Asn Gly Tyr Asn Tyr 
1               5                   10      


<210>  625
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  625

Leu Gly Ser 
1           


<210>  626
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  626

Met Gln Ala Leu Gln Thr Pro Phe Thr 
1               5                   


<210>  627
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  627

Gln Ser Val Ser Ser Asn 
1               5       


<210>  628
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  628

Gly Ala Ser 
1           


<210>  629
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  629

Gln Gln Tyr Asn Tyr Trp Pro Pro Leu Thr 
1               5                   10  


<210>  630
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  630

Asn Ile Gly Ser Lys Ser 
1               5       


<210>  631
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  631

Asp Asp Ser 
1           


<210>  632
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  632

Gln Val Trp Asp Ser Ser Ser Asp His His Val Val 
1               5                   10          


<210>  633
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  633

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  634
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  634

Ile Asn Ser 
1           


<210>  635
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  635

Gln Ser Tyr Asp Ser Ser Leu Gly Ala Leu 
1               5                   10  


<210>  636
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  636

Gln Ser Ile Ser Ser Phe 
1               5       


<210>  637
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  637

Ala Ala Phe 
1           


<210>  638
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  638

Gln Gln Ser Tyr Asn Thr Pro Tyr Thr 
1               5                   


<210>  639
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  639

Gln Ser Val Ser Ser Tyr 
1               5       


<210>  640
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  640

Asp Ala Ser 
1           


<210>  641
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  641

Gln His Arg Ser Asn Trp Pro Pro Arg Leu Thr 
1               5                   10      


<210>  642
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  642

Gln Ser Val Ser Ser Asn 
1               5       


<210>  643
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  643

Gly Ala Ser 
1           


<210>  644
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  644

Gln Gln Tyr Asn Asn Phe Leu Thr 
1               5               


<210>  645
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  645

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  646
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  646

Glu Asp Asn 
1           


<210>  647
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  647

Gln Ser Tyr Asp Gly Ser Asn His Ala Val Val 
1               5                   10      


<210>  648
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  648

Ser Ser Asn Ile Gly Ser Asn Thr 
1               5               


<210>  649
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  649

Ser Asn Asn 
1           


<210>  650
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  650

Ala Ala Trp Asp Asp Ser Leu Asn Ala Leu Val 
1               5                   10      


<210>  651
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  651

Gln Ser Ile Ala Gly Tyr 
1               5       


<210>  652
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  652

Gly Thr Thr 
1           


<210>  653
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  653

Gln Gln Ser Tyr Ser Thr Pro Gly Thr 
1               5                   


<210>  654
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  654

Gln Asp Ile Asn His Tyr 
1               5       


<210>  655
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  655

Asp Ala Ser 
1           


<210>  656
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  656

Gln Gln Ser Asp Asn Leu Pro Met Tyr Thr 
1               5                   10  


<210>  657
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  657

Asn Ile Gly Ser Lys Ser 
1               5       


<210>  658
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  658

Asp Asp Ser 
1           


<210>  659
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  659

Gln Val Trp Asp Ser Ser Ser Asp His His Val Val 
1               5                   10          


<210>  660

<400>  660
000

<210>  661

<400>  661
000

<210>  662

<400>  662
000

<210>  663
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  663

Asn Ser Asn Ile Gly Ser Tyr Thr 
1               5               


<210>  664
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  664

Asp Asn Asn 
1           


<210>  665
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  665

Leu Val Trp Asp Asp Ser Leu Asn Gly Leu Val 
1               5                   10      


<210>  666
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  666

Ser Ser Asn Ile Gly Ser Gly Ser Asp 
1               5                   


<210>  667
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  667

Gly Asn Thr 
1           


<210>  668
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  668

Gln Ser Tyr Asp Ser Arg Leu Ser Gly Phe Val Val 
1               5                   10          


<210>  669
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  669

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  670
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  670

Ala Ala Ser 
1           


<210>  671
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  671

Gln Gln Ser Tyr Ser Thr Pro Gln Thr 
1               5                   


<210>  672
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  672

Gln Ser Ile Ser Asn Tyr 
1               5       


<210>  673
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  673

Ala Ala Ser 
1           


<210>  674
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  674

Gln Gln Ser Tyr Thr Thr Leu Leu Thr 
1               5                   


<210>  675

<400>  675
000

<210>  676

<400>  676
000

<210>  677

<400>  677
000

<210>  678
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  678

Asn Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  679
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  679

Gly Asn Ser 
1           


<210>  680
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  680

Gln Ser Tyr Asp Ser Ser Leu Ser Asp Ser Val 
1               5                   10      


<210>  681

<400>  681
000

<210>  682

<400>  682
000

<210>  683

<400>  683
000

<210>  684
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  684

Gln Ser Val Ser Ser Asn 
1               5       


<210>  685
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  685

Gly Ala Ser 
1           


<210>  686
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  686

Gln Gln Tyr Tyr Asn Trp Pro Leu Thr 
1               5                   


<210>  687
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  687

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  688
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  688

Asp Lys Asn 
1           


<210>  689
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  689

Asn Ser Arg Asp Ser Ser Gly Asn Ala Val Val 
1               5                   10      


<210>  690
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  690

Gln Asp Ile Ser Asn Tyr 
1               5       


<210>  691
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  691

Asp Ala Ser 
1           


<210>  692
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  692

Gln Gln Tyr Ala Asn Leu Pro Phe Thr 
1               5                   


<210>  693

<400>  693
000

<210>  694

<400>  694
000

<210>  695

<400>  695
000

<210>  696

<400>  696
000

<210>  697

<400>  697
000

<210>  698

<400>  698
000

<210>  699
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  699

Gln Asn Ile Ala Ser Tyr 
1               5       


<210>  700
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  700

Ala Ala Ser 
1           


<210>  701
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  701

Gln Gln Ser Tyr Ser Thr Pro Trp Thr 
1               5                   


<210>  702
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  702

Gln Ser Val Arg Ser Asn 
1               5       


<210>  703
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  703

Gly Ala Ser 
1           


<210>  704
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  704

His Gln Tyr Asn Asn Trp Pro Gln Thr 
1               5                   


<210>  705
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  705

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  706
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  706

Glu Asp Asn 
1           


<210>  707
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  707

Gln Ser Tyr Asp Gly Ile Asn Arg Ala Trp Val 
1               5                   10      


<210>  708
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  708

Gln Ser Leu Leu His Ser Leu Gly Tyr Asn Ser 
1               5                   10      


<210>  709
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  709

Leu Gly Ser 
1           


<210>  710
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  710

Met Gln Ala Leu Gln Thr Pro Leu Thr 
1               5                   


<210>  711
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  711

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  712
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  712

Ala Ala Ser 
1           


<210>  713
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  713

Gln Gln Ser Tyr Ser Ser Leu Ser Ile Thr 
1               5                   10  


<210>  714
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  714

Gln Ser Ile Ser Ser Tyr 
1               5       


<210>  715
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  715

Ala Ala Ser 
1           


<210>  716
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  716

Gln Gln Ser Tyr Glu Ile Pro Pro Trp Thr 
1               5                   10  


<210>  717
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  717

Gln Asp Ile Asn Asn Tyr 
1               5       


<210>  718
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  718

Asp Ala Ser 
1           


<210>  719
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  719

Gln Gln Tyr Asp Asn Leu Pro Pro Val 
1               5                   


<210>  720
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  720

Ser Ser Asn Ile Gly Ala Gly Tyr Asp 
1               5                   


<210>  721
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  721

Ala Asn Ser 
1           


<210>  722
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  722

Gln Ser Tyr Asp Ser Ser Leu Ser Gly Ser Val 
1               5                   10      


<210>  723
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  723

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  724
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  724

Glu Asp Asn 
1           


<210>  725
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  725

Gln Ser Tyr Asp Ser Gly Asn Pro Ile 
1               5                   


<210>  726

<400>  726
000

<210>  727

<400>  727
000

<210>  728

<400>  728
000

<210>  729
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  729

Gln Asp Ile Asn Asn Tyr 
1               5       


<210>  730
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  730

Asp Ala Ser 
1           


<210>  731
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  731

Gln Gln Tyr Asp Asn Leu Pro Pro Val 
1               5                   


<210>  732
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  732

Ser Gly Ser Ile Ala Ser Asn Tyr 
1               5               


<210>  733
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  733

Glu Asp Asn 
1           


<210>  734
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  734

Gln Ser Tyr Asp Gly Ile Asn Arg Trp Leu Val 
1               5                   10      


<210>  735
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  735

Ser Gly Tyr Ser Asn Tyr Lys 
1               5           


<210>  736
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  736

Val Gly Thr Gly Gly Ile Val Gly 
1               5               


<210>  737
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  737

Gly Ala Asp His Gly Ser Gly Ser Asn Phe Glu Tyr Val Val 
1               5                   10                  


<210>  738
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  738

Ser Ser Asn Ile Gly Tyr Asn Ile 
1               5               


<210>  739
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  739

Ser Asn Asn 
1           


<210>  740
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  740

Ala Ala Trp Asp Asp Ser Leu Asn Gly Tyr Val 
1               5                   10      


<210>  741
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  741

Asn Ile Gly Asn Lys Gly 
1               5       


<210>  742
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  742

Asp Asp Ser 
1           


<210>  743
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  743

Gln Val Trp Asp Ser Ser Ser Asp His Pro Gly Val 
1               5                   10          


<210>  744
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  744

Gln Gly Ile Ser Ser Tyr 
1               5       


<210>  745
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  745

Ala Ala Ser 
1           


<210>  746
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  746

Gln Gln Leu Asn Ser Tyr Pro Val Thr 
1               5                   


<210>  747
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  747

Ser Ser Asp Val Gly Asp Tyr Asn Tyr 
1               5                   


<210>  748
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  748

Asp Val Ser 
1           


<210>  749
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  749

Ser Ser Tyr Thr Ser Ser Ser Thr Leu Leu Tyr Val 
1               5                   10          


<210>  750
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  750

Gln Ser Val Ser Ser Phe 
1               5       


<210>  751
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  751

Asp Ala Ser 
1           


<210>  752
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  752

His Tyr Arg Ser Asn Trp Pro Pro Val Leu Thr 
1               5                   10      


<210>  753
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  753

Gln Ser Val Ser Ser Phe 
1               5       


<210>  754
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  754

Asp Ala Ser 
1           


<210>  755
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  755

Gln His Arg Thr Asn Trp Pro Pro Leu Phe Thr 
1               5                   10      


<210>  756
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  756

Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Ser 
1               5                   10          


<210>  757
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  757

Trp Ala Ser 
1           


<210>  758
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  758

Gln Gln Tyr Tyr Ser Ile Ser Trp Thr 
1               5                   


<210>  759
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  759

Gln Asp Ile Thr Asn Tyr 
1               5       


<210>  760
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  760

Asp Ala Ser 
1           


<210>  761
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  761

Gln Gln Tyr Asp Asn Leu Tyr Ser Val His 
1               5                   10  


<210>  762
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  762

Ala Leu Pro Arg Gln Tyr 
1               5       


<210>  763
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  763

Lys Asp Ser 
1           


<210>  764
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  764

Gln Ser Ala Asp Thr Ile Gly Thr Tyr Trp Val 
1               5                   10      


<210>  765
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  765

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  766
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  766

Gln Asp Thr 
1           


<210>  767
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  767

Gln Ala Trp Gly Ser Ser Arg Gly Val 
1               5                   


<210>  768
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  768

Gln Ser Val Ser Ser Tyr 
1               5       


<210>  769
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  769

Asp Ala Ser 
1           


<210>  770
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  770

His Lys Arg Ser Asn Trp Pro Pro Ser Leu Thr 
1               5                   10      


<210>  771
<211>  360
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  771
gaggtgcagc tggtggagtc tgggggagac ttggtacagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttcgc agctatgcca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagct attagtgata atgcttatag cacatactac      180

gcagactccg tgaagggccg gttcaccatc tccagagaca attccaagaa cactctgtat      240

ctgcaaatga acagcctgag agccgaggac acggccatat attactgtgc gaagaatctt      300

tatagtggaa actccccatt tgactactgg ggccagggaa ccctggtcac cgtctcctca      360


<210>  772
<211>  317
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody


<220>
<221>  misc_feature
<222>  (1)..(3)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  n is a, c, g, or t

<400>  772
nnntntgtgc tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggggataaa tatgcttgct ggtatcagca gaagccaggc      120

cagtcccctg tgctggtcat ctatcaagat agcaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg gacagcagca ctgccgtctt cggaactggg      300

accaaggtca ccgtcct                                                     317


<210>  773
<211>  390
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  773
gaggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt agttatggca tgcattgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatggcatg atggaagtaa gaaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagagatcaa      300

ggtggatatg attacgtttg ggggagttat cgatatacat tttacgtctt tgactactgg      360

ggccagggaa ccctggtcac cgtctcctca                                       390


<210>  774
<211>  390
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  774
gaggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cgtctggatt caccttcagt agttatggca tgcattgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatggcatg atggaagtaa gaaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagagatcaa      300

ggtggatatg attacgtttg ggggagttat cgatatacat tttacgtctt tgactactgg      360

ggccagggaa ccctggtcac cgtctcctca                                       390


<210>  775
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  775
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttagt ttctattgga tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtggccaac ataaagcaag atggaagtga gaaatactat      180

gtggactctg tgaagggccg attcagcatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagagttggt      300

agcagcagct ggtattttga ctactggggc cagggaaccc tggtcaccgt ctcctca         357


<210>  776
<211>  317
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody


<220>
<221>  misc_feature
<222>  (1)..(4)
<223>  n is a, c, g, or t

<400>  776
nnnnttgtgc tgactcagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggggataaa tatgcttgct ggtatcagca gaagccaggc      120

cagtcccctg tgctggtcat ctatcaagat atcaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg gacagcaaca ctggagtgtt cggcggaggg      300

accaagctga ccgtcct                                                     317


<210>  777
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  777
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggata caccctcacc aggtatgata tccactgggt gcgacaggcc      120

actggacaag ggcttgagtg gatgggatgg ttgaacccta acggtggcaa cacaggctat      180

gcacagaagt tccagggcag agtcaccatg accagaaaca ccgccataag cacagcctac      240

atggagctga gcagcctgag atctgaggac gcggccgtgt attactgtgc gaggggtcag      300

tgggaactag acgcttggta cttcgatctc tggggccgtg gcaccctggt caccgtctcc      360

tca                                                                    363


<210>  778
<211>  329
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody


<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  n is a, c, g, or t

<400>  778
cagtntgtgc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacagctt cagaagctat tatgcaagct ggtaccagca gaagccagga      120

caggcccctg tacttgtcat ctatggtaaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattattg taactcccgg gacaccagtg gtaaccatct agatgtggta      300

ttcggcggag ggaccaagct gaccgtcct                                        329


<210>  779
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  779
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctggggcctc actgaaggtc       60

tcctgcaagg cttctggata caccttcacc cgttatgata tcaactgggt gcgacaggcc      120

actggacaag ggcttgagtg gatgggatgg atgaacccta acagtgataa cacaggctat      180

gcacagaagt tccaggacag agtcaccatg accaggaaca cctccataag cacagtctac      240

atggagctga gcagcctgag atctgaggac acggccgtgt attactgtgc gaggggtcag      300

tgggagctag acgtttggta cttcgatctc tggggccgtg gcaccctggt caccgtctcc      360

tca                                                                    363


<210>  780
<211>  329
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody


<220>
<221>  misc_feature
<222>  (4)..(5)
<223>  n is a, c, g, or t

<400>  780
cagnntgtgc tgactcagga ccctgctgtg tctgtggcct tgggacagac actcaggatc       60

acatgccaag gagacagcct cagaagctat tatgcaagct ggtaccagca gaagccagga      120

caggcccctg tacttgtcat ctatggtaaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattactg taactcccgg gacagcagcg gtcaccatct agatgtggta      300

ttcggcggag ggaccaagct gaccgtcct                                        329


<210>  781
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  781
caggtgcagc tgcaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcagt agttactact ggagctggat ccggcagccc      120

ccagggaagg gactggagtg gattgggtgt atctattaca gtgggcgcac caactacagc      180

ccctccctca agagtcgagt caccatatca gtagacacgt ccaagaacct gttctccctg      240

aagctgagct ctgtgaccgc tgcggacacg gccgtgtatt actgtgcgag aggaggccgc      300

cctggggctg aaggacctta tgatgctttt gatatctggg gccaagggac aatggtcacc      360

gtctcctca                                                              369


<210>  782
<211>  323
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody


<220>
<221>  misc_feature
<222>  (4)..(5)
<223>  n is a, c, g, or t

<400>  782
cagnntgtgc tgactcagga ccctgctgtg tctgtggcct tgggacagac agtcaggatc       60

acatgccaag gagacaacct cagaaggtat tatgcaagct ggtaccagca gaagccagga      120

caggcccctg tactagtcat ctatggtaaa aacaaccggc cctcagggat cccagaccga      180

ttctctggct ccagctcagg aaacacagct tccttgacca tcactggggc tcaggcggaa      240

gatgaggctg actattactg taactcccgg gacagcagtg gtaaccatgt ggtattcggc      300

ggagggacca cgctgaccgt cct                                              323


<210>  783
<211>  370
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  783
caggtgcagc tggtgcaatc tgggtctgag ttgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg cttctggata caccttcagt gactatgcta tgaattgggt gcgacaggcc      120

cctggacaag gacttgagtg gatgggatgg atgaagtcta acagtggtaa cacaggctat      180

gcacagaagt tccagggcag agtcactatg accaggaaca cctccataag tacagcctac      240

atggagttga ccagcctgag atctgaggac acggccgtgt attactgtgc gagaatgcgc      300

agtggctggc ccacacatgg ccgcccggat gaccactggg gccggggagc cctggtcacc      360

gtctcctcag                                                             370


<210>  784
<211>  325
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  784
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtgggaga cagagtcacc       60

atcacttgcc gggcaagtca gagcattatc agctatttaa attggtatca ccagaaaccg      120

gggaaagccc ctaaactcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tctgataatc tccccatgta cacttttggc      300

caggggacca agctggagat caaac                                            325


<210>  785
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  785
caggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcgtt acctctggca tacactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gaaaggaggg      300

ccaaacaagg aagtactata tttcggggag ttattggact acggtatgga cgtctggggc      360

caagggacca cggtcaccgt ctcctca                                          387


<210>  786
<211>  343
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  786
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagttccg aaattaagaa ctacttagct      120

tggtatcagc agaaaccagg acagcctcct aagctgctca tttactgggc atctacccgg      180

gaattcgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtggt      300

cccctggaca cttttggcca ggggaccaag ctggagatca aac                        343


<210>  787
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  787
caggtccagc ttgtgcagtc tggggctgag gtgaagaagc ctggggcctc agtgaaggtt       60

tcctgcaagg tctctggata caccttcact ggctatgttg tacattgggt gcgccaggcc      120

cccggacaag accttgagtg gatgggatgg atcaacactg gctacggcaa cacaaaatat      180

tcacagaagt tccagggcag ggtcactatt agctgggaca catccgcgac gacagcctac      240

atggagctga gcaacctgaa atctgaggac aaggctgttt attactgtgc gagtatgaac      300

cggatgtcag agcaaactta ctacggaatg gacgtctggg gccaggggac cacggtcacc      360

gtctcc                                                                 366


<210>  788
<211>  316
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  788
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc aggcgagtca ggacattagc aactatttaa attggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctacgat gcatccaatt tggaaacagg ggtcccatca      180

aggttcagtg gaagtggatc tgggacagat tttactttca ccatcagcag cctgcagcct      240

gaagatattg caacatatta ctgtcaacag tatgataagc tcactctcgg cggagggacc      300

aaggtggaga tcaaac                                                      316


<210>  789
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  789
caggtgcagc tacagcagtg gggcgcagga ctgttgaagc cttcggagac cctgtccctc       60

acctgcgctg tctatggtgg gtccttcagt ggttactact ggagctggat ccgccagccc      120

ccagggaagg ggctggagtg gattggggaa atcaatcata gtggaagcac caactacaat      180

ccgtccctca agagtcgagt caccatatca gtggacacgt ccaagaacca cttctccctg      240

aaaatgaact ctgtgaccgc cgcggacacg gctgtgtatt actgtgcgag atgtcgccag      300

atggggaact tctactacta ctacatggac gtctggggca aggggaccac ggtcaccgtc      360

tcc                                                                    363


<210>  790
<211>  334
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  790
cagtctgtgc tgacgcagcc gccctcagtg tctggggtcc cagggcagag ggtcaccgtc       60

tcctgcactg ggagcagctc caacatcggg gcaggttttg atgtatattg gtaccagcag      120

tttctaggaa cagcccccaa actcctcatc tatggcaaca acaatcggcc ctcaggcgtc      180

cctgaccgat tctctgcctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgaag atgaggctga ttattactgc cagtcctttg acatcggccg gggtggttgg      300

attttcggcg gagggaccaa gctgaccgtc ctag                                  334


<210>  791
<211>  382
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  791
caggtgcacc tacaggagtc gggcccagga ctggtgaagc cttcggagac cctgtccctc       60

acctgcactg tctctggtgg ctccatcaat aattattact ggagctggat ccggcagccc      120

ccggggaagg gactggagtg gattggggaa atccattaca gtgggagcac cagctacagc      180

ccctccctca agagtcgact cagcatatca gtagacaggt ccaagaacca gttctccctg      240

aagctggcct ctgtgaccgc tgcagacacg gccgtgtatt actgtgtgag ggataattac      300

tttgataata gtggtcatcc tgtgtatccg gttccctggt tcgacccctg gggccaggga      360

accctggtca ccgtctcctc ag                                               382


<210>  792
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  792
cagtctgtgc tgacgcagcc gccctcagtg tctggggtcc cagggcagag ggtcaccgtc       60

tcctgcactg ggagcagctc caacatcggg gcaggttttg atgtatattg gtaccagcag      120

tttctaggaa cagcccccaa actcctcatc tatggcaaca acaatcggcc ctcaggcgtc      180

cctgaccgat tctctgcctc caagtctggc acctcagcct ccctggccat cactgggctc      240

caggctgaag atgaggctga ttattactgc cagtcctttg acatcggccg gggtggttgg      300

attttcggcg gagggaccaa gctcaccgtc c                                     331


<210>  793
<211>  352
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  793
caggttcagg tggtgcagtc tggagctgag gtaaagaagc ctggggcctc agtgaaggtc       60

tcctgcaagg cttctggtta cacctttaag aactatggga tcagttgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggatgg atcagcgctt acacaggaaa cacaaactat      180

gcacagaagt tccagggcag aatgaccatg accacagaca catccacggg aacaggttat      240

atggaactga ggagcctgag atctgacgac acggccgtgt attactgtgc gagagtacaa      300

cgacgtcgac ttgactactg gggccaggga accctggtca tcgtctcgtc ag              352


<210>  794
<211>  331
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  794
gatattgtgg tgacccagac tccactctct ctgtccgtca cccctggaca gccggcctcc       60

atctcctgca agtctagtga gaccctcctg catagtgatg gaaagaccta tttgtcttgg      120

tatctgcaga agccaggcca gcctccacag ctcctgatct atgaagtttc caaccggttc      180

tctggagtgc cagacaggtt cagtggcagc gggtcaggaa cagatttcac acttaaaatc      240

ggccgggtgg aggctgagga tgttgggctt tattactgca tgcaaagtat acagctcgcc      300

ttcggccaag ggacacgact ggaaattgaa c                                     331


<210>  795
<211>  372
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  795
gaggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acgtatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacactatat      240

ctgcaaatga tcggcctgag agctgaggac acggctgtgt attactgtgc gagagattgg      300

gcacctacgt actacgatat gccgagtgct tttgatatct ggggccaagg gacaatggtc      360

accgtctctt ca                                                          372


<210>  796
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  796
tcctatgagc tgacacagcc accctcggtg tcagtggccc caggaaagac ggccaggatt       60

acctgtgggg gaaacaacat tggaaataaa ggtgtgcatt ggtaccagca gaagccaggc      120

caggcccctg tgctggtcgt cgatgatgat agcgaccggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacggcc accctgatca tcagcagtgt cgaagtcggg      240

gatgaggccg acttttactg tcaggtgtgg gatagtagta gtgatcatcc gggggtgttc      300

ggcggaggga ccaagctgac cgtccta                                          327


<210>  797
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  797
gaggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggaatg ggtggcagtt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagaagcacg      300

agtgggagct actactacgg tatggacgtc tggggccaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  798
<211>  336
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  798
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt gattataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga atattactgc agctcatata caagcagcag cactctactt      300

tatgtcttcg gaactgggac caaggtcacc gtccta                                336


<210>  799
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  799
gaggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggaatg ggtggcagtt atatcatatg atggaagcaa taaatactac      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag agctgaggac acggctgtgt attactgtgc gagaagcacg      300

agtgggagct actactacgg tatggacgtc tggggccaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  800
<211>  336
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  800
cagtctgccc tgactcagcc tgcctccgtg tctgggtctc ctggacagtc gatcaccatc       60

tcctgcactg gaaccagcag tgacgttggt gattataact atgtctcctg gtaccaacaa      120

cacccaggca aagcccccaa actcatgatt tatgatgtca gtaatcggcc ctcaggggtt      180

tctaatcgct tctctggctc caagtctggc aacacggcct ccctgaccat ctctgggctc      240

caggctgagg acgaggctga atattactgc agctcatata caagcagcag cactctactt      300

tatgtcttcg gaactgggac caaggtcacc gtccta                                336


<210>  801
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  801
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcatctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtac aacaaactac      180

gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgag cacagcctac      240

gtggaactga gcagcctgag atctgaggac acggccgtgt attattgtgc gagaataggc      300

cattttgata gtagtggtta ttacttagac tactggggcc agggaaccct ggtcaccgtc      360

tcctca                                                                 366


<210>  802
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  802
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcttcttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca ggcccactgg catcccagcc      180

aggttcactg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagattttg cagtttatta ctgtcagcac cgtaccaact ggcctccctt attcactttc      300

ggccctggga ccaaagtgga tatcaaa                                          327


<210>  803
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  803
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtgc agcaaactac      180

gcacagaact tccagggcag agtcacgatt accgcggacg aatccacgag cacaggctac      240

atgcaactga gcagcctgag atttgaggac acggccgtgt attactgtgc gagaacgtct      300

cactatgata gtagtggttc ctattttgaa tactggggcc agggaaccct ggtcaccgtc      360

tcctca                                                                 366


<210>  804
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  804
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agctacttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagaccct      240

gaagattttg cagtttatta ctgtcacaag cgtagcaact ggcctccttc gctcactttc      300

ggcggaggga ccaaggtgga aatcaaa                                          327


<210>  805
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  805
gaggtgcagc tggtggagtc tgggggaggc ttggtccagc ctggggggtc cctgagactc       60

tcctgtgtag cctctggatt cacctttagt ttctattgga tgagctgggt ccgccaggct      120

ccaggaaagg ggctcgagtg ggtggccaac ataaagcaag atggaggtga gaaatactat      180

gtggactctg tgaagggccg attcaccatc tccagagaca acgccaagaa ctcactgtat      240

ctgcaaatga acagcctgag agccgaggac acggctgtgt attactgtgc gagactgtct      300

ggcagcagct gggactttga ctactggggc cagggaaccc tggtcaccgt ctcctca         357


<210>  806
<211>  318
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  806
tcctatgagc tgacacagcc accctcagtg tccgtgtccc caggacagac agccagcatc       60

acctgctctg gagataaatt gggggataaa tatgcttgtt ggtaccaaca gaggccaggc      120

cagtcccctg tgctggtcat ctatcaagat agtaagcggc cctcagggat ccctgagcga      180

ttctctggct ccaactctgg gaacacagcc actctgacca tcagcgggac ccaggctatg      240

gatgaggctg actattactg tcaggcgtgg gacagcagca ctggagtctt cggaactggg      300

accaaggtca ccgtccta                                                    318


<210>  807
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  807
gaggtgcagc tggtggagtc tgggggaggt gtggtacggc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatggca tgagctgggt ccgccaagct      120

ccagggaagg ggctggagtg ggtctctgct attaattgga atggtggtag cacaggttat      180

gcagactctg taaagggccg attcaccatc tccagagata atgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agccgaggac acggccttgt atcactgtgc gagacggcgt      300

agctcgtccc ggtatagcag tggctggtat atgtactact actacatgga cgtctggggc      360

aaagggacca cggtcaccgt ctcctca                                          387


<210>  808
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  808
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtgttagt acctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaacctcct gatctatgag gcgtctagtt tagaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacttatta ctgccaacag tataatactt attcggggac gttcggccaa      300

gggaccaagg tggaaatcaa a                                                321


<210>  809
<211>  387
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  809
gaggtgcagc tggtggagtc tgggggaggt gtggtacggc ctggggggtc cctgagactc       60

tcctgtgcag cctctggatt cacctttgat gattatggca tgagctgggt ccgccaagct      120

ccagggaagg ggctggagtg ggtctctgct attaattgga atggtggtag cacaggttat      180

gcagactctg taaagggccg attcaccatc tccagagata atgccaagaa ctccctgtat      240

ctgcaaatga acagtctgag agccgaggac acggccttgt atcactgtgc gagacggcgt      300

agctcgtccc ggtatagcag tggctggtat atgtactact actacatgga cgtctggggc      360

aaagggacca cggtcaccgt ctcctca                                          387


<210>  810
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  810
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca gagtgttagt acctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaacctcct gatctatgag gcgtctagtt tagaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacttatta ctgccaacag tataatactt attcggggac gttcggccaa      300

gggaccaagg tggaaatcaa a                                                321


<210>  811
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  811
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtgc agcaaactac      180

gcacagaact tccagggcag agtcacgatt accgcggacg aatccacgag cacaggctac      240

atgcaactga gcagcctgag atttgaggac acggccgtgt attactgtgc gagaacgtct      300

cactatgata gtagtggttc ctattttgaa tactggggcc agggaaccct ggtcaccgtc      360

tcctca                                                                 366


<210>  812
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  812
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agctacttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagaccct      240

gaagattttg cagtttatta ctgtcacaag cgtagcaact ggcctccttc gctcactttc      300

ggcggaggga ccaaggtgga gatcaaa                                          327


<210>  813
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  813
gaggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acctatgcta tgcactgggt ccgccaggct      120

ccaggcaagg ggctggcgtg ggtggcactt atatcatatg atggatataa taaatactac      180

gcagactccg tgaggggccg attcaccatc tccagaatca attccaagaa cacgctgtct      240

ctgcagatga acagcctgag agctgaggac acggctgtct attactgtgc gagagggtca      300

gctggaaact actactacgg tatggacgtc tggggccagg ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  814
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  814
gacatccaga tgacccagtc tccatcctcc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggcaagtca gaccattacc aactatttaa attggtatca gctgaaatca      120

gggagagccc ccaagctcct gatctatgct gcatccagtt tgcaaagtgg ggtcccatca      180

aggttcagtg gcagtggatc tgggacagat ttcactctca ccatcagcag tctgcaacct      240

gaagattttg caacttacta ctgtcaacag agttacagta cgccgtacac ttttggccag      300

gggaccaagg tggagatcaa a                                                321


<210>  815
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  815
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcatctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtac aacaaactac      180

gcacagaagt tccagggcag agtcacgatt accgcggacg aatccacgag cacagcctac      240

gtggaactga gcagcctgag atctgaggac acggccgtgt attattgtgc gagaataggc      300

cattttgata gtagtggtta ttacttagac tactggggcc agggaaccct ggtcaccgtc      360

tcctca                                                                 366


<210>  816
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  816
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccaggaga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcttcttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca ggcccactgg catcccagcc      180

aggttcactg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagagcct      240

gaagattttg cagtttatta ctgtcagcac cgtaccaact ggcctccctt attcactttc      300

ggccctggga ccaaagtgga tatcaaa                                          327


<210>  817
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  817
gaggtgcagc tggtgcagtc tggggctgag gtgaagaagc ctgggtcctc ggtgaaggtc       60

tcctgcaagg cttctggagg caccttcagc agctatgcta tcagctgggt gcgacaggcc      120

cctggacaag ggcttgagtg gatgggaggg atcatcccta tctttggtgc agcaaactac      180

gcacagaact tccagggcag agtcacgatt accgcggacg aatccacgag cacaggctac      240

atgcaactga gcagcctgag atttgaggac acggccgtgt attactgtgc gagaacgtct      300

cactatgata gtagtggttc ctattttgaa tactggggcc agggaaccct ggtcaccgtc      360

tcctca                                                                 366


<210>  818
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  818
gaaattgtgt tgacacagtc tccagccacc ctgtctttgt ctccagggga aagagccacc       60

ctctcctgca gggccagtca gagtgttagc agctacttag cctggtacca acagaaacct      120

ggccaggctc ccaggctcct catctatgat gcatccaaca gggccactgg catcccagcc      180

aggttcagtg gcagtgggtc tgggacagac ttcactctca ccatcagcag cctagaccct      240

gaagattttg cagtttatta ctgtcacaag cgtagcaact ggcctccttc gctcactttc      300

ggcggaggga ccaaggtgga aatcaaa                                          327


<210>  819
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  819
gaggtgcagc tggtggagtc tgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt agttatgctc tgttctgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atttcatatg atggaaataa taaatactac      180

gcagactccg tgaggggccg attcaccatc tccagagaca attccaagaa cacgctgtat      240

ctgcaaatga acagcctgag acctgaggac acggctgtgt attactgtgc gagaccatat      300

actgggagct acaagagcta catggacgtc tggggcaaag ggaccacggt caccgtctcc      360

tca                                                                    363


<210>  820
<211>  339
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  820
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtttta tacagctcca acaataagaa ctccttagct      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tttactgggc atctacccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtatattact gtcagcaata ttatagtatt      300

tcttggacgt tcggccaagg gaccaaggtg gaaatcaaa                             339


<210>  821
<211>  354
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  821
gaggtgcagc tggtggagtc cgggggaggc gtggtccagc ctgggaggtc cctgagactc       60

tcctgtgcag cctctggatt caccttcagt acctatggca tgcactgggt ccgccaggct      120

ccaggcaagg ggctggagtg ggtggcagtt atatcatatg atggaagtaa taaatactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca attccaagaa cacactgtat      240

ctgcaaatga acagcctgag agctgaggac acggctatgt attactgtgc gaaagatggg      300

agtatagcag cagctgacta ctggggccag ggaaccctgg tcaccgtctc ctca            354


<210>  822
<211>  339
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  822
gacatcgtga tgacccagtc tccagactcc ctggctgtgt ctctgggcga gagggccacc       60

atcaactgca agtccagcca gagtgtctta cacagctcca acaacaagga ctccttagtt      120

tggtaccagc agaaaccagg acagcctcct aagctgctca tttactgggc atctagccgg      180

gaatccgggg tccctgaccg attcagtggc agcgggtctg ggacagattt cactctcacc      240

atcagcagcc tgcaggctga agatgtggca gtttattact gtcagcaata ttatagtact      300

ccttggacgt tcggccaagg gaccaaggtg gaaatcaaa                             339


<210>  823
<211>  336
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  823
gaggtgcagc tggtggagtc tggaggaggc ttgatccagc ctggggggtc cctgagactc       60

tcctgtgcag cctctgggtt catcgtcagt agcaactaca tgagctgggt ccgccaggct      120

ccagggaagg ggctggagtg ggtctcagtt atttatagcg gtggtagcac atactacgca      180

gactccgtga agggccgatt caccatctcc agagacaatt ccaagaacac gctgtatctt      240

caaatgaaca gcctgagagc cgaggacacg gccgtatatt actgtgcgag agagagcacg      300

caatggggcc agggaaccct ggtcaccgtc tcctca                                336


<210>  824
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  824
gacatccaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagtca cagtattagt agctggttgg cctggtatca gcagaaacca      120

gggaaagccc ctaagctcct gatctataag gcgtctagtt tagaaagtgg ggtcccatca      180

aggttcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagcct      240

gatgattttg caacttatta ctgccaacag tataatactt attctcaaac gttcggccaa      300

gggaccaagg tggagatcaa a                                                321


<210>  825
<211>  369
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  825
gaggtgcagc tggtgcagtc tgggcctgag gtgaagaagc ctgggacctc agtgaaggtc       60

tcctgcaagg cttctggatt cacctttatg agctctgctg tgcagtgggt gcgacaggct      120

cgtggacaac gccttgagtg gataggatgg atcgtcattg gcagtggtaa cacaaactac      180

gcacagaagt tccaggaaag agtcaccatt accagggaca tgtccacaag cacagcctac      240

atggagctga gcagcctgag atccgaggac acggccgtgt attactgtgc ggccccatat      300

tgtagtagta tcagctgcaa tgatggtttt gatatctggg gccaagggac aatggtcacc      360

gtctcttca                                                              369


<210>  826
<211>  327
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  826
gaaattgtgt tgacgcagtc tccaggcacc ctgtctttgt ctccagggga gagagccacc       60

ctctcctgca gggccagtca gagtgttagc agcagctact tagcctggta ccagcagaaa      120

cctggccagg ctcccaggct cctcatctat ggtgcatcca gcagggccac tggcatccca      180

gacaggttca gtggcagtgg gtctgggaca gacttcactc tcaccatcag cagactggag      240

cctgaagatt ttgcagtgta ttactgtcag cactatggta gctcacgggg ttggacgttc      300

ggccaaggga ccaaggtgga aatcaaa                                          327


<210>  827
<211>  120
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  827

Glu Val Gln Leu Val Glu Ser Gly Gly Asp Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Arg Ser Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Ser Asp Asn Ala Tyr Ser Thr Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Ile Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asn Leu Tyr Ser Gly Asn Ser Pro Phe Asp Tyr Trp Gly Gln 
            100                 105                 110         


Gly Thr Leu Val Thr Val Ser Ser 
        115                 120 


<210>  828
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody


<220>
<221>  misc_feature
<222>  (1)..(2)
<223>  Xaa can be any naturally occurring amino acid

<400>  828

Xaa Xaa Val Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Gln Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Ala Val 
                85                  90                  95      


Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105     


<210>  829
<211>  130
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  829

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Trp His Asp Gly Ser Lys Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Gln Gly Gly Tyr Asp Tyr Val Trp Gly Ser Tyr Arg Tyr 
            100                 105                 110         


Thr Phe Tyr Val Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val 
        115                 120                 125             


Ser Ser 
    130 


<210>  830
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody


<220>
<221>  misc_feature
<222>  (1)..(2)
<223>  Xaa can be any naturally occurring amino acid

<400>  830

Xaa Xaa Val Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Asn Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Val Val Met Tyr 
        35                  40                  45              


Gly Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Val Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Ser Ser Gly Asn His 
                85                  90                  95      


Leu Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105             


<210>  831
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  831

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Phe Tyr 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Ser Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Ser Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Gly Ser Ser Ser Trp Tyr Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  832
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody


<220>
<221>  misc_feature
<222>  (1)..(2)
<223>  Xaa can be any naturally occurring amino acid

<400>  832

Xaa Xaa Val Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Tyr Gln Gln Lys Pro Gly Gln Ser Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Gln Asp Ile Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Asn Thr Gly Val 
                85                  90                  95      


Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105     


<210>  833
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  833

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Leu Thr Arg Tyr 
            20                  25                  30          


Asp Ile His Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Leu Asn Pro Asn Gly Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asn Thr Ala Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Ala Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Gln Trp Glu Leu Asp Ala Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  834
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<400>  834

Gln Xaa Val Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Phe Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Gly Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Thr Ser Gly Asn His 
                85                  90                  95      


Leu Asp Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  835
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  835

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Leu Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Arg Tyr 
            20                  25                  30          


Asp Ile Asn Trp Val Arg Gln Ala Thr Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Asn Ser Asp Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Asp Arg Val Thr Met Thr Arg Asn Thr Ser Ile Ser Thr Val Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Gln Trp Glu Leu Asp Val Trp Tyr Phe Asp Leu Trp Gly 
            100                 105                 110         


Arg Gly Thr Leu Val Thr Val Ser Ser 
        115                 120     


<210>  836
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<400>  836

Gln Xaa Val Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Leu Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Gly Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Ser Ser Gly His His 
                85                  90                  95      


Leu Asp Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110 


<210>  837
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  837

Gln Val Gln Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Ser Ser Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Cys Ile Tyr Tyr Ser Gly Arg Thr Asn Tyr Ser Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn Leu Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ser Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Gly Gly Arg Pro Gly Ala Glu Gly Pro Tyr Asp Ala Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  838
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<400>  838

Gln Xaa Val Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln 
1               5                   10                  15      


Thr Val Arg Ile Thr Cys Gln Gly Asp Asn Leu Arg Arg Tyr Tyr Ala 
            20                  25                  30          


Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Gly Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser 
    50                  55                  60                  


Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Ser Ser Gly Asn His 
                85                  90                  95      


Val Val Phe Gly Gly Gly Thr Thr Leu Thr Val Leu 
            100                 105             


<210>  839
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  839

Gln Val Gln Leu Val Gln Ser Gly Ser Glu Leu Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Ser Asp Tyr 
            20                  25                  30          


Ala Met Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Lys Ser Asn Ser Gly Asn Thr Gly Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asn Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Thr Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Met Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp His 
            100                 105                 110         


Trp Gly Arg Gly Ala Leu Val Thr Val Ser Ser 
        115                 120             


<210>  840
<211>  108
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  840

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ile Ser Tyr 
            20                  25                  30          


Leu Asn Trp Tyr His Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Ser Asp Asn Leu Pro Met 
                85                  90                  95      


Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys 
            100                 105             


<210>  841
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  841

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Val Thr Ser 
            20                  25                  30          


Gly Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Gly Gly Pro Asn Lys Glu Val Leu Tyr Phe Gly Glu Leu Leu 
            100                 105                 110         


Asp Tyr Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  842
<211>  114
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  842

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Glu Ile Lys Asn Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Phe Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Gly Pro Leu Asp Thr Phe Gly Gln Gly Thr Lys Leu Glu 
            100                 105                 110         


Ile Lys 
        


<210>  843
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  843

Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Val Ser Gly Tyr Thr Phe Thr Gly Tyr 
            20                  25                  30          


Val Val His Trp Val Arg Gln Ala Pro Gly Gln Asp Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Thr Gly Tyr Gly Asn Thr Lys Tyr Ser Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Ser Trp Asp Thr Ser Ala Thr Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Asn Leu Lys Ser Glu Asp Lys Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ser Met Asn Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
            100                 105                 110         


Trp Gly Gln Gly Thr Thr Val Thr Val Ser 
        115                 120         


<210>  844
<211>  105
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  844

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Gln Ala Ser Gln Asp Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Leu Glu Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Tyr Asp Lys Leu Thr Leu 
                85                  90                  95      


Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105 


<210>  845
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  845

Gln Val Gln Leu Gln Gln Trp Gly Ala Gly Leu Leu Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Ala Val Tyr Gly Gly Ser Phe Ser Gly Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile Asn His Ser Gly Ser Thr Asn Tyr Asn Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Val Thr Ile Ser Val Asp Thr Ser Lys Asn His Phe Ser Leu 
65                  70                  75                  80  


Lys Met Asn Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Cys Arg Gln Met Gly Asn Phe Tyr Tyr Tyr Tyr Met Asp Val Trp 
            100                 105                 110         


Gly Lys Gly Thr Thr Val Thr Val Ser 
        115                 120     


<210>  846
<211>  111
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  846

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Val Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Val Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Phe Asp Val Tyr Trp Tyr Gln Gln Phe Leu Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Asn Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Ala Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Phe Asp Ile Gly 
                85                  90                  95      


Arg Gly Gly Trp Ile Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 110     


<210>  847
<211>  127
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  847

Gln Val His Leu Gln Glu Ser Gly Pro Gly Leu Val Lys Pro Ser Glu 
1               5                   10                  15      


Thr Leu Ser Leu Thr Cys Thr Val Ser Gly Gly Ser Ile Asn Asn Tyr 
            20                  25                  30          


Tyr Trp Ser Trp Ile Arg Gln Pro Pro Gly Lys Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Glu Ile His Tyr Ser Gly Ser Thr Ser Tyr Ser Pro Ser Leu Lys 
    50                  55                  60                  


Ser Arg Leu Ser Ile Ser Val Asp Arg Ser Lys Asn Gln Phe Ser Leu 
65                  70                  75                  80  


Lys Leu Ala Ser Val Thr Ala Ala Asp Thr Ala Val Tyr Tyr Cys Val 
                85                  90                  95      


Arg Asp Asn Tyr Phe Asp Asn Ser Gly His Pro Val Tyr Pro Val Pro 
            100                 105                 110         


Trp Phe Asp Pro Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120                 125         


<210>  848
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  848

Gln Ser Val Leu Thr Gln Pro Pro Ser Val Ser Gly Val Pro Gly Gln 
1               5                   10                  15      


Arg Val Thr Val Ser Cys Thr Gly Ser Ser Ser Asn Ile Gly Ala Gly 
            20                  25                  30          


Phe Asp Val Tyr Trp Tyr Gln Gln Phe Leu Gly Thr Ala Pro Lys Leu 
        35                  40                  45              


Leu Ile Tyr Gly Asn Asn Asn Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Ala Ser Lys Ser Gly Thr Ser Ala Ser Leu Ala Ile Thr Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln Ser Phe Asp Ile Gly 
                85                  90                  95      


Arg Gly Gly Trp Ile Phe Gly Gly Gly Thr Lys Leu Thr Val 
            100                 105                 110 


<210>  849
<211>  117
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  849

Gln Val Gln Val Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Lys Asn Tyr 
            20                  25                  30          


Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Ser Ala Tyr Thr Gly Asn Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Met Thr Met Thr Thr Asp Thr Ser Thr Gly Thr Gly Tyr 
65                  70                  75                  80  


Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Val Gln Arg Arg Arg Leu Asp Tyr Trp Gly Gln Gly Thr Leu 
            100                 105                 110         


Val Ile Val Ser Ser 
        115         


<210>  850
<211>  110
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  850

Asp Ile Val Val Thr Gln Thr Pro Leu Ser Leu Ser Val Thr Pro Gly 
1               5                   10                  15      


Gln Pro Ala Ser Ile Ser Cys Lys Ser Ser Glu Thr Leu Leu His Ser 
            20                  25                  30          


Asp Gly Lys Thr Tyr Leu Ser Trp Tyr Leu Gln Lys Pro Gly Gln Pro 
        35                  40                  45              


Pro Gln Leu Leu Ile Tyr Glu Val Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Gly Arg Val Glu Ala Glu Asp Val Gly Leu Tyr Tyr Cys Met Gln Ser 
                85                  90                  95      


Ile Gln Leu Ala Phe Gly Gln Gly Thr Arg Leu Glu Ile Glu 
            100                 105                 110 


<210>  851
<211>  124
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  851

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Ile Gly Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Trp Ala Pro Thr Tyr Tyr Asp Met Pro Ser Ala Phe Asp 
            100                 105                 110         


Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120                 


<210>  852
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  852

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ala Pro Gly Lys 
1               5                   10                  15      


Thr Ala Arg Ile Thr Cys Gly Gly Asn Asn Ile Gly Asn Lys Gly Val 
            20                  25                  30          


His Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Val Asp 
        35                  40                  45              


Asp Asp Ser Asp Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Ile Ile Ser Ser Val Glu Val Gly 
65                  70                  75                  80  


Asp Glu Ala Asp Phe Tyr Cys Gln Val Trp Asp Ser Ser Ser Asp His 
                85                  90                  95      


Pro Gly Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
            100                 105                 


<210>  853
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  853

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Thr Ser Gly Ser Tyr Tyr Tyr Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  854
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  854

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Asp Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Glu Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr Leu Leu Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110         


<210>  855
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  855

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ser Thr Ser Gly Ser Tyr Tyr Tyr Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  856
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  856

Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Asp Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Asn Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Glu Tyr Tyr Cys Ser Ser Tyr Thr Ser Ser 
                85                  90                  95      


Ser Thr Leu Leu Tyr Val Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105                 110         


<210>  857
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  857

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ile Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Val Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Gly His Phe Asp Ser Ser Gly Tyr Tyr Leu Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  858
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  858

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Phe 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Pro Thr Gly Ile Pro Ala Arg Phe Thr Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln His Arg Thr Asn Trp Pro Pro 
                85                  90                  95      


Leu Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105                 


<210>  859
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  859

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Ala Ala Asn Tyr Ala Gln Asn Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Gly Tyr 
65                  70                  75                  80  


Met Gln Leu Ser Ser Leu Arg Phe Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Thr Ser His Tyr Asp Ser Ser Gly Ser Tyr Phe Glu Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  860
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  860

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Asp Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys His Lys Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Ser Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  861
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  861

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Val Ala Ser Gly Phe Thr Phe Ser Phe Tyr 
            20                  25                  30          


Trp Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Asn Ile Lys Gln Asp Gly Gly Glu Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Ser Gly Ser Ser Trp Asp Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  862
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  862

Ser Tyr Glu Leu Thr Gln Pro Pro Ser Val Ser Val Ser Pro Gly Gln 
1               5                   10                  15      


Thr Ala Ser Ile Thr Cys Ser Gly Asp Lys Leu Gly Asp Lys Tyr Ala 
            20                  25                  30          


Cys Trp Tyr Gln Gln Arg Pro Gly Gln Ser Pro Val Leu Val Ile Tyr 
        35                  40                  45              


Gln Asp Ser Lys Arg Pro Ser Gly Ile Pro Glu Arg Phe Ser Gly Ser 
    50                  55                  60                  


Asn Ser Gly Asn Thr Ala Thr Leu Thr Ile Ser Gly Thr Gln Ala Met 
65                  70                  75                  80  


Asp Glu Ala Asp Tyr Tyr Cys Gln Ala Trp Asp Ser Ser Thr Gly Val 
                85                  90                  95      


Phe Gly Thr Gly Thr Lys Val Thr Val Leu 
            100                 105     


<210>  863
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  863

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Arg Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Gly Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Asn Trp Asn Gly Gly Ser Thr Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr His Cys 
                85                  90                  95      


Ala Arg Arg Arg Ser Ser Ser Arg Tyr Ser Ser Gly Trp Tyr Met Tyr 
            100                 105                 110         


Tyr Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  864
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  864

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Thr Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Asn Leu Leu Ile 
        35                  40                  45              


Tyr Glu Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Thr Tyr Ser Gly 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  865
<211>  129
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  865

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Arg Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Asp Asp Tyr 
            20                  25                  30          


Gly Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Ala Ile Asn Trp Asn Gly Gly Ser Thr Gly Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Ser Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Leu Tyr His Cys 
                85                  90                  95      


Ala Arg Arg Arg Ser Ser Ser Arg Tyr Ser Ser Gly Trp Tyr Met Tyr 
            100                 105                 110         


Tyr Tyr Tyr Met Asp Val Trp Gly Lys Gly Thr Thr Val Thr Val Ser 
        115                 120                 125             


Ser 
    


<210>  866
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  866

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Val Ser Thr Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Asn Leu Leu Ile 
        35                  40                  45              


Tyr Glu Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Thr Tyr Ser Gly 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  867
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  867

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Ala Ala Asn Tyr Ala Gln Asn Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Gly Tyr 
65                  70                  75                  80  


Met Gln Leu Ser Ser Leu Arg Phe Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Thr Ser His Tyr Asp Ser Ser Gly Ser Tyr Phe Glu Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  868
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  868

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Asp Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys His Lys Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Ser Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  869
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  869

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Ala Trp Val 
        35                  40                  45              


Ala Leu Ile Ser Tyr Asp Gly Tyr Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Ile Ser Arg Ile Asn Ser Lys Asn Thr Leu Ser 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Ser Ala Gly Asn Tyr Tyr Tyr Gly Met Asp Val Trp Gly 
            100                 105                 110         


Gln Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  870
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  870

Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Thr Ile Thr Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Leu Lys Ser Gly Arg Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Ser Tyr Ser Thr Pro Tyr 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  871
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  871

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ile Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Thr Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Val Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Ile Gly His Phe Asp Ser Ser Gly Tyr Tyr Leu Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  872
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  872

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Phe 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Pro Thr Gly Ile Pro Ala Arg Phe Thr Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Glu Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln His Arg Thr Asn Trp Pro Pro 
                85                  90                  95      


Leu Phe Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105                 


<210>  873
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  873

Glu Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Gly Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Gly Ile Ile Pro Ile Phe Gly Ala Ala Asn Tyr Ala Gln Asn Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Ile Thr Ala Asp Glu Ser Thr Ser Thr Gly Tyr 
65                  70                  75                  80  


Met Gln Leu Ser Ser Leu Arg Phe Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Thr Ser His Tyr Asp Ser Ser Gly Ser Tyr Phe Glu Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
        115                 120         


<210>  874
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  874

Glu Ile Val Leu Thr Gln Ser Pro Ala Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Tyr 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Asp Ala Ser Asn Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Asp Pro 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys His Lys Arg Ser Asn Trp Pro Pro 
                85                  90                  95      


Ser Leu Thr Phe Gly Gly Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  875
<211>  121
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  875

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr 
            20                  25                  30          


Ala Leu Phe Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Asn Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Arg Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Pro Tyr Thr Gly Ser Tyr Lys Ser Tyr Met Asp Val Trp Gly 
            100                 105                 110         


Lys Gly Thr Thr Val Thr Val Ser Ser 
        115                 120     


<210>  876
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  876

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu Tyr Ser 
            20                  25                  30          


Ser Asn Asn Lys Asn Ser Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Ile Ser Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  877
<211>  118
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  877

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Tyr 
            20                  25                  30          


Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Met Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Gly Ser Ile Ala Ala Ala Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  878
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  878

Asp Ile Val Met Thr Gln Ser Pro Asp Ser Leu Ala Val Ser Leu Gly 
1               5                   10                  15      


Glu Arg Ala Thr Ile Asn Cys Lys Ser Ser Gln Ser Val Leu His Ser 
            20                  25                  30          


Ser Asn Asn Lys Asp Ser Leu Val Trp Tyr Gln Gln Lys Pro Gly Gln 
        35                  40                  45              


Pro Pro Lys Leu Leu Ile Tyr Trp Ala Ser Ser Arg Glu Ser Gly Val 
    50                  55                  60                  


Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr 
65                  70                  75                  80  


Ile Ser Ser Leu Gln Ala Glu Asp Val Ala Val Tyr Tyr Cys Gln Gln 
                85                  90                  95      


Tyr Tyr Ser Thr Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile 
            100                 105                 110         


Lys 
    


<210>  879
<211>  112
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  879

Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Ile Gln Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Ile Val Ser Ser Asn 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Val Ile Tyr Ser Gly Gly Ser Thr Tyr Tyr Ala Asp Ser Val Lys 
    50                  55                  60                  


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr Leu 
65                  70                  75                  80  


Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys Ala 
                85                  90                  95      


Arg Glu Ser Thr Gln Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
            100                 105                 110         


<210>  880
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  880

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser His Ser Ile Ser Ser Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile 
        35                  40                  45              


Tyr Lys Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Thr Tyr Ser Gln 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  881
<211>  123
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  881

Glu Val Gln Leu Val Gln Ser Gly Pro Glu Val Lys Lys Pro Gly Thr 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Phe Thr Phe Met Ser Ser 
            20                  25                  30          


Ala Val Gln Trp Val Arg Gln Ala Arg Gly Gln Arg Leu Glu Trp Ile 
        35                  40                  45              


Gly Trp Ile Val Ile Gly Ser Gly Asn Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Glu Arg Val Thr Ile Thr Arg Asp Met Ser Thr Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Ala Pro Tyr Cys Ser Ser Ile Ser Cys Asn Asp Gly Phe Asp Ile 
            100                 105                 110         


Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser 
        115                 120             


<210>  882
<211>  109
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  882

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Ser 
            20                  25                  30          


Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln His Tyr Gly Ser Ser Arg 
                85                  90                  95      


Gly Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  883
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  883

Gly Phe Thr Phe Arg Ser Tyr Ala 
1               5               


<210>  884
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  884

Ile Ser Asp Asn Ala Tyr Ser Thr 
1               5               


<210>  885
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  885

Ala Lys Asn Leu Tyr Ser Gly Asn Ser Pro Phe Asp Tyr 
1               5                   10              


<210>  886
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  886

Gly Phe Thr Phe Ser Ser Tyr Gly 
1               5               


<210>  887
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  887

Ile Trp His Asp Gly Ser Lys Lys 
1               5               


<210>  888
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  888

Ala Arg Asp Gln Gly Gly Tyr Asp Tyr Val Trp Gly Ser Tyr Arg Tyr 
1               5                   10                  15      


Thr Phe Tyr Val Phe Asp Tyr 
            20              


<210>  889
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  889

Gly Phe Thr Phe Ser Phe Tyr Trp 
1               5               


<210>  890
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  890

Ile Lys Gln Asp Gly Ser Glu Lys 
1               5               


<210>  891
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  891

Ala Arg Val Gly Ser Ser Ser Trp Tyr Phe Asp Tyr 
1               5                   10          


<210>  892
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  892

Gly Tyr Thr Leu Thr Arg Tyr Asp 
1               5               


<210>  893
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  893

Leu Asn Pro Asn Gly Gly Asn Thr 
1               5               


<210>  894
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  894

Ala Arg Gly Gln Trp Glu Leu Asp Ala Trp Tyr Phe Asp Leu 
1               5                   10                  


<210>  895
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  895

Gly Tyr Thr Phe Thr Arg Tyr Asp 
1               5               


<210>  896
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  896

Met Asn Pro Asn Ser Asp Asn Thr 
1               5               


<210>  897
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  897

Ala Arg Gly Gln Trp Glu Leu Asp Val Trp Tyr Phe Asp Leu 
1               5                   10                  


<210>  898
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  898

Gly Gly Ser Ile Ser Ser Tyr Tyr 
1               5               


<210>  899
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  899

Ile Tyr Tyr Ser Gly Arg Thr 
1               5           


<210>  900
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  900

Ala Arg Gly Gly Arg Pro Gly Ala Glu Gly Pro Tyr Asp Ala Phe Asp 
1               5                   10                  15      


Ile 
    


<210>  901
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  901

Gly Tyr Thr Phe Ser Asp Tyr Ala 
1               5               


<210>  902
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  902

Met Lys Ser Asn Ser Gly Asn Thr 
1               5               


<210>  903
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  903

Ala Arg Met Arg Ser Gly Trp Pro Thr His Gly Arg Pro Asp Asp His 
1               5                   10                  15      


<210>  904
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  904

Gly Phe Thr Phe Val Thr Ser Gly 
1               5               


<210>  905
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  905

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  906
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  906

Ala Lys Gly Gly Pro Asn Lys Glu Val Leu Tyr Phe Gly Glu Leu Leu 
1               5                   10                  15      


Asp Tyr Gly Met Asp Val 
            20          


<210>  907
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  907

Gly Tyr Thr Phe Thr Gly Tyr Val 
1               5               


<210>  908
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  908

Ile Asn Thr Gly Tyr Gly Asn Thr 
1               5               


<210>  909
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  909

Ala Ser Met Asn Arg Met Ser Glu Gln Thr Tyr Tyr Gly Met Asp Val 
1               5                   10                  15      


<210>  910
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  910

Gly Gly Ser Phe Ser Gly Tyr Tyr 
1               5               


<210>  911
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  911

Ile Asn His Ser Gly Ser Thr 
1               5           


<210>  912
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  912

Ala Arg Cys Arg Gln Met Gly Asn Phe Tyr Tyr Tyr Tyr Met Asp Val 
1               5                   10                  15      


<210>  913
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  913

Gly Gly Ser Ile Asn Asn Tyr Tyr 
1               5               


<210>  914
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  914

Ile His Tyr Ser Gly Ser Thr 
1               5           


<210>  915
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  915

Val Arg Asp Asn Tyr Phe Asp Asn Ser Gly His Pro Val Tyr Pro Val 
1               5                   10                  15      


Pro Trp Phe Asp Pro 
            20      


<210>  916
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  916

Gly Tyr Thr Phe Lys Asn Tyr Gly 
1               5               


<210>  917
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  917

Ile Ser Ala Tyr Thr Gly Asn Thr 
1               5               


<210>  918
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  918

Ala Arg Val Gln Arg Arg Arg Leu Asp Tyr 
1               5                   10  


<210>  919
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  919

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  920
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  920

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  921
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  921

Ala Arg Asp Trp Ala Pro Thr Tyr Tyr Asp Met Pro Ser Ala Phe Asp 
1               5                   10                  15      


Ile 
    


<210>  922
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  922

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  923
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  923

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  924
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  924

Ala Arg Ser Thr Ser Gly Ser Tyr Tyr Tyr Gly Met Asp Val 
1               5                   10                  


<210>  925
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  925

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  926
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  926

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  927
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  927

Ala Arg Ser Thr Ser Gly Ser Tyr Tyr Tyr Gly Met Asp Val 
1               5                   10                  


<210>  928
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  928

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  929
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  929

Ile Ile Pro Ile Phe Gly Thr Thr 
1               5               


<210>  930
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  930

Ala Arg Ile Gly His Phe Asp Ser Ser Gly Tyr Tyr Leu Asp Tyr 
1               5                   10                  15  


<210>  931
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  931

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  932
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  932

Ile Ile Pro Ile Phe Gly Ala Ala 
1               5               


<210>  933
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  933

Ala Arg Thr Ser His Tyr Asp Ser Ser Gly Ser Tyr Phe Glu Tyr 
1               5                   10                  15  


<210>  934
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  934

Gly Phe Thr Phe Ser Phe Tyr Trp 
1               5               


<210>  935
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  935

Ile Lys Gln Asp Gly Gly Glu Lys 
1               5               


<210>  936
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  936

Ala Arg Leu Ser Gly Ser Ser Trp Asp Phe Asp Tyr 
1               5                   10          


<210>  937
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  937

Gly Phe Thr Phe Asp Asp Tyr Gly 
1               5               


<210>  938
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  938

Ile Asn Trp Asn Gly Gly Ser Thr 
1               5               


<210>  939
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  939

Ala Arg Arg Arg Ser Ser Ser Arg Tyr Ser Ser Gly Trp Tyr Met Tyr 
1               5                   10                  15      


Tyr Tyr Tyr Met Asp Val 
            20          


<210>  940
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  940

Gly Phe Thr Phe Asp Asp Tyr Gly 
1               5               


<210>  941
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  941

Ile Asn Trp Asn Gly Gly Ser Thr 
1               5               


<210>  942
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  942

Ala Arg Arg Arg Ser Ser Ser Arg Tyr Ser Ser Gly Trp Tyr Met Tyr 
1               5                   10                  15      


Tyr Tyr Tyr Met Asp Val 
            20          


<210>  943
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  943

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  944
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  944

Ile Ile Pro Ile Phe Gly Ala Ala 
1               5               


<210>  945
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  945

Ala Arg Thr Ser His Tyr Asp Ser Ser Gly Ser Tyr Phe Glu Tyr 
1               5                   10                  15  


<210>  946
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  946

Gly Phe Thr Phe Ser Thr Tyr Ala 
1               5               


<210>  947
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  947

Ile Ser Tyr Asp Gly Tyr Asn Lys 
1               5               


<210>  948
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  948

Ala Arg Gly Ser Ala Gly Asn Tyr Tyr Tyr Gly Met Asp Val 
1               5                   10                  


<210>  949
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  949

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  950
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  950

Ile Ile Pro Ile Phe Gly Thr Thr 
1               5               


<210>  951
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  951

Ala Arg Ile Gly His Phe Asp Ser Ser Gly Tyr Tyr Leu Asp Tyr 
1               5                   10                  15  


<210>  952
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  952

Gly Gly Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  953
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  953

Ile Ile Pro Ile Phe Gly Ala Ala 
1               5               


<210>  954
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  954

Ala Arg Thr Ser His Tyr Asp Ser Ser Gly Ser Tyr Phe Glu Tyr 
1               5                   10                  15  


<210>  955
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  955

Gly Phe Thr Phe Ser Ser Tyr Ala 
1               5               


<210>  956
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  956

Ile Ser Tyr Asp Gly Asn Asn Lys 
1               5               


<210>  957
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  957

Ala Arg Pro Tyr Thr Gly Ser Tyr Lys Ser Tyr Met Asp Val 
1               5                   10                  


<210>  958
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  958

Gly Phe Thr Phe Ser Thr Tyr Gly 
1               5               


<210>  959
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  959

Ile Ser Tyr Asp Gly Ser Asn Lys 
1               5               


<210>  960
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  960

Ala Lys Asp Gly Ser Ile Ala Ala Ala Asp Tyr 
1               5                   10      


<210>  961
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  961

Gly Phe Ile Val Ser Ser Asn Tyr 
1               5               


<210>  962
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  962

Ile Tyr Ser Gly Gly Ser Thr 
1               5           


<210>  963
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  963

Ala Arg Glu Ser Thr Gln 
1               5       


<210>  964
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  964

Gly Phe Thr Phe Met Ser Ser Ala 
1               5               


<210>  965
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  965

Ile Val Ile Gly Ser Gly Asn Thr 
1               5               


<210>  966
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  966

Ala Ala Pro Tyr Cys Ser Ser Ile Ser Cys Asn Asp Gly Phe Asp Ile 
1               5                   10                  15      


<210>  967
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  967

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  968
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  968

Gln Asp Ser 
1           


<210>  969
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  969

Gln Ala Trp Asp Ser Ser Thr Ala Val 
1               5                   


<210>  970
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  970

Ser Leu Arg Asn Tyr Tyr 
1               5       


<210>  971
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  971

Gly Lys Asn 
1           


<210>  972
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  972

Asn Ser Arg Asp Ser Ser Gly Asn His Leu Ile 
1               5                   10      


<210>  973
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  973

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  974
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  974

Gln Asp Ile 
1           


<210>  975
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  975

Gln Ala Trp Asp Ser Asn Thr Gly Val 
1               5                   


<210>  976
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  976

Ser Phe Arg Ser Tyr Tyr 
1               5       


<210>  977
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  977

Gly Lys Asn 
1           


<210>  978
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  978

Asn Ser Arg Asp Thr Ser Gly Asn His Leu Asp Val Val 
1               5                   10              


<210>  979
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  979

Ser Leu Arg Ser Tyr Tyr 
1               5       


<210>  980
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  980

Gly Lys Asn 
1           


<210>  981
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  981

Asn Ser Arg Asp Ser Ser Gly His His Leu Asp Val Val 
1               5                   10              


<210>  982
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  982

Asn Leu Arg Arg Tyr Tyr 
1               5       


<210>  983
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  983

Gly Lys Asn 
1           


<210>  984
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  984

Asn Ser Arg Asp Ser Ser Gly Asn His Val Val 
1               5                   10      


<210>  985
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  985

Gln Ser Ile Ile Ser Tyr 
1               5       


<210>  986
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  986

Ala Ala Ser 
1           


<210>  987
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  987

Gln Gln Ser Asp Asn Leu Pro Met Tyr Thr 
1               5                   10  


<210>  988
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  988

Gln Ser Val Leu Tyr Ser Ser Glu Ile Lys Asn Tyr 
1               5                   10          


<210>  989
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  989

Trp Ala Ser 
1           


<210>  990
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  990

Gln Gln Tyr Tyr Ser Gly Pro Leu Asp Thr 
1               5                   10  


<210>  991
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  991

Gln Asp Ile Ser Asn Tyr 
1               5       


<210>  992
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  992

Asp Ala Ser 
1           


<210>  993
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  993

Gln Gln Tyr Asp Lys Leu Thr 
1               5           


<210>  994
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  994

Ser Ser Asn Ile Gly Ala Gly Phe Asp 
1               5                   


<210>  995
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  995

Gly Asn Asn 
1           


<210>  996
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  996

Gln Ser Phe Asp Ile Gly Arg Gly Gly Trp Ile 
1               5                   10      


<210>  997
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  997

Ser Ser Asn Ile Gly Ala Gly Phe Asp 
1               5                   


<210>  998
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  998

Gly Asn Asn 
1           


<210>  999
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  999

Gln Ser Phe Asp Ile Gly Arg Gly Gly Trp Ile 
1               5                   10      


<210>  1000
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1000

Glu Thr Leu Leu His Ser Asp Gly Lys Thr Tyr 
1               5                   10      


<210>  1001
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1001

Glu Val Ser 
1           


<210>  1002
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1002

Met Gln Ser Ile Gln Leu Ala 
1               5           


<210>  1003
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1003

Asn Ile Gly Asn Lys Gly 
1               5       


<210>  1004
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1004

Asp Asp Ser 
1           


<210>  1005
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1005

Gln Val Trp Asp Ser Ser Ser Asp His Pro Gly Val 
1               5                   10          


<210>  1006
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1006

Ser Ser Asp Val Gly Asp Tyr Asn Tyr 
1               5                   


<210>  1007
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1007

Asp Val Ser 
1           


<210>  1008
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1008

Ser Ser Tyr Thr Ser Ser Ser Thr Leu Leu Tyr Val 
1               5                   10          


<210>  1009
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1009

Ser Ser Asp Val Gly Asp Tyr Asn Tyr 
1               5                   


<210>  1010
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1010

Asp Val Ser 
1           


<210>  1011
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1011

Ser Ser Tyr Thr Ser Ser Ser Thr Leu Leu Tyr Val 
1               5                   10          


<210>  1012
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1012

Gln Ser Val Ser Ser Phe 
1               5       


<210>  1013
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1013

Asp Ala Ser 
1           


<210>  1014
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1014

Gln His Arg Thr Asn Trp Pro Pro Leu Phe Thr 
1               5                   10      


<210>  1015
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1015

Gln Ser Val Ser Ser Tyr 
1               5       


<210>  1016
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1016

Asp Ala Ser 
1           


<210>  1017
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1017

His Lys Arg Ser Asn Trp Pro Pro Ser Leu Thr 
1               5                   10      


<210>  1018
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1018

Lys Leu Gly Asp Lys Tyr 
1               5       


<210>  1019
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1019

Gln Asp Ser 
1           


<210>  1020
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1020

Gln Ala Trp Asp Ser Ser Thr Gly Val 
1               5                   


<210>  1021
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1021

Gln Ser Val Ser Thr Trp 
1               5       


<210>  1022
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1022

Glu Ala Ser 
1           


<210>  1023
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1023

Gln Gln Tyr Asn Thr Tyr Ser Gly Thr 
1               5                   


<210>  1024
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1024

Gln Ser Val Ser Thr Trp 
1               5       


<210>  1025
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1025

Glu Ala Ser 
1           


<210>  1026
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1026

Gln Gln Tyr Asn Thr Tyr Ser Gly Thr 
1               5                   


<210>  1027
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1027

Asp Ala Ser 
1           


<210>  1028
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1028

His Lys Arg Ser Asn Trp Pro Pro Ser Leu Thr 
1               5                   10      


<210>  1029
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1029

Gln Thr Ile Thr Asn Tyr 
1               5       


<210>  1030
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1030

Ala Ala Ser 
1           


<210>  1031
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1031

Gln Gln Ser Tyr Ser Thr Pro Tyr Thr 
1               5                   


<210>  1032
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1032

Gln Ser Val Ser Ser Phe 
1               5       


<210>  1033
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1033

Asp Ala Ser 
1           


<210>  1034
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1034

Gln His Arg Thr Asn Trp Pro Pro Leu Phe Thr 
1               5                   10      


<210>  1035
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1035

Gln Ser Val Ser Ser Tyr 
1               5       


<210>  1036
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1036

Asp Ala Ser 
1           


<210>  1037
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1037

His Lys Arg Ser Asn Trp Pro Pro Ser Leu Thr 
1               5                   10      


<210>  1038
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1038

Gln Ser Val Leu Tyr Ser Ser Asn Asn Lys Asn Ser 
1               5                   10          


<210>  1039
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1039

Trp Ala Ser 
1           


<210>  1040
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1040

Gln Gln Tyr Tyr Ser Ile Ser Trp Thr 
1               5                   


<210>  1041
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1041

Gln Ser Val Leu His Ser Ser Asn Asn Lys Asp Ser 
1               5                   10          


<210>  1042
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1042

Trp Ala Ser 
1           


<210>  1043
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1043

Gln Gln Tyr Tyr Ser Thr Pro Trp Thr 
1               5                   


<210>  1044
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1044

His Ser Ile Ser Ser Trp 
1               5       


<210>  1045
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1045

Lys Ala Ser 
1           


<210>  1046
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1046

Gln Gln Tyr Asn Thr Tyr Ser Gln Thr 
1               5                   


<210>  1047
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1047

Gln Ser Val Ser Ser Ser Tyr 
1               5           


<210>  1048
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1048

Gly Ala Ser 
1           


<210>  1049
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1049

Gln His Tyr Gly Ser Ser Arg Gly Trp Thr 
1               5                   10  


<210>  1050
<211>  108
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1050

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Phe Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  1051
<211>  109
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1051

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Phe Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Pro Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  1052
<211>  108
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1052

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Phe Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Leu 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  1053
<211>  108
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1053

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Phe Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Ser 
                85                  90                  95      


Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105             


<210>  1054
<211>  109
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1054

Glu Ile Val Leu Thr Gln Ser Pro Gly Thr Leu Ser Leu Ser Pro Gly 
1               5                   10                  15      


Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn 
            20                  25                  30          


Phe Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu 
        35                  40                  45              


Ile Tyr Gly Ala Ser Ser Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser 
    50                  55                  60                  


Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Arg Leu Glu 
65                  70                  75                  80  


Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Gly Ser Ser Pro 
                85                  90                  95      


Thr Trp Thr Phe Gly Gln Gly Thr Lys Val Glu Ile Lys 
            100                 105                 


<210>  1055
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1055

Ile Gly Trp Ile Val Cys Ala Ala 
1               5               


<210>  1056
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1056

Gly Tyr Cys Ser Ser Thr Ser Cys Tyr Ala 
1               5                   10  


<210>  1057
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1057

Gly Tyr Cys Thr Asn Gly Val Cys Tyr Ala 
1               5                   10  


<210>  1058
<211>  22
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1058

Gly Tyr Cys Ser Gly Gly Ser Cys Tyr Ser Ser Ser Tyr Leu Ala Trp 
1               5                   10                  15      


Gln Tyr Gly Ser Ser Pro 
            20          


<210>  1059
<211>  10
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1059

Asp Ala Phe Asp Ile Trp Trp Thr Phe Gly 
1               5                   10  


<210>  1060
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1060

Ile Gly Trp Ile Val Cys Ala Ala Pro Tyr Cys Ser Ser Ile Ser Cys 
1               5                   10                  15      


Asn Asp Gly Phe Asp Ile Trp Ser Ser Tyr Leu Ala Trp His Tyr Gly 
            20                  25                  30          


Ser Ser Arg Gly Arg Trp Phe Gly 
        35                  40  


<210>  1061
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1061

Ile Gly Trp Ile Gln Cys Ala Ala Pro Tyr Cys Ser Arg Thr Ser Cys 
1               5                   10                  15      


His Asp Ala Phe Asp Ile Trp Ser Ser Tyr Leu Ala Trp His Phe Gly 
            20                  25                  30          


Ser Ser Ser Gln Trp Thr Phe Gly 
        35                  40  


<210>  1062
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1062

Ile Gly Trp Ile Val Cys Ala Ala Pro His Cys Asn Arg Thr Ser Cys 
1               5                   10                  15      


Tyr Asp Ala Phe Asp Leu Trp Ser Ser Tyr Leu Gly Trp Gln Tyr Gly 
            20                  25                  30          


Ser Ser Pro Trp Thr Phe Gly 
        35                  


<210>  1063
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1063

Ile Gly Trp Ile Val Cys Ala Ala Pro Arg Cys Ser Ser Gly Gly Ser 
1               5                   10                  15      


Cys Tyr Asp Gly Phe Asp Ile Trp Ser Ser Tyr Leu Ala Trp Gln Tyr 
            20                  25                  30          


Gly Ser Ser Pro Trp Thr Phe Gly 
        35                  40  


<210>  1064
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1064

Ile Gly Trp Ile Val Cys Ala Ala Pro Tyr Cys Ser Ser Thr Arg Cys 
1               5                   10                  15      


Tyr Asp Ala Phe Asp Ile Trp Ser Ser Tyr Leu Ala Trp Gln Tyr Gly 
            20                  25                  30          


Arg Ser Pro Trp Thr Phe Gly 
        35                  


<210>  1065
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1065

Ile Gly Trp Ile Val Cys Ala Ala Pro His Cys Ser Ser Thr Ile Cys 
1               5                   10                  15      


Tyr Asp Gly Phe Asp Ile Trp Ser Ser Tyr Leu Ala Trp Gln Tyr Gly 
            20                  25                  30          


Ser Ser Pro Trp Thr Phe Gly 
        35                  


<210>  1066
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1066

Val Gly Trp Ile Val Cys Ala Ser Pro Tyr Cys Ser Gly Gly Ser Cys 
1               5                   10                  15      


Ser Asp Gly Phe Asp Ile Trp Ser Ser Tyr Leu Ala Trp Gln Tyr Val 
            20                  25                  30          


Gly Leu Thr Gly Trp Thr Phe Gly 
        35                  40  


<210>  1067
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1067

Ile Gly Trp Ile Val Cys Ala Ala Pro His Cys Ser Ser Thr Ser Cys 
1               5                   10                  15      


Gly Asp Ala Phe Asp Ile Trp Ser Ser Tyr Leu Ala Trp Gln Tyr Gly 
            20                  25                  30          


Asn Ser Pro Trp Thr Phe Gly 
        35                  


<210>  1068
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1068

Ile Gly Trp Ile Val Cys Ala Ala Pro Tyr Cys Ser Gly Gly Ser Cys 
1               5                   10                  15      


Ser Asp Ala Phe Asp Ile Trp Ser Ser Tyr Leu Ala Trp Gln Tyr Gly 
            20                  25                  30          


Ser Ser Pro Trp Thr Phe Gly 
        35                  


<210>  1069
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1069

Ile Gly Trp Ile Val Cys Ala Ala Val Asp Cys Asn Ser Thr Ser Cys 
1               5                   10                  15      


Tyr Asp Ala Phe Asp Ile Trp Ser Ser Tyr Leu Ala Trp Gln Tyr Asp 
            20                  25                  30          


Ile Ser Pro Trp Thr Phe Gly 
        35                  


<210>  1070
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1070

Ile Gly Trp Ile Val Cys Ala Ala Pro His Cys Ser Gly Gly Ser Cys 
1               5                   10                  15      


Leu Asp Ala Phe Asp Ile Trp Ser Ser Tyr Leu Ala Trp Gln Tyr Gly 
            20                  25                  30          


Ser Ser Pro Trp Thr Phe Gly 
        35                  


<210>  1071
<211>  39
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1071

Ile Gly Trp Ile Val Cys Ala Ala Pro His Cys Ser Gly Gly Ser Cys 
1               5                   10                  15      


Tyr Asp Ala Phe Asp Ile Trp Ser Ser Tyr Leu Ala Trp Gln Tyr Gly 
            20                  25                  30          


Ser Ser Pro Trp Thr Phe Gly 
        35                  


<210>  1072
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1072

Ile Gly Trp Ile Val Cys Ala Ala Asn His Cys Ser Ser Gly Gly Ser 
1               5                   10                  15      


Cys Tyr Asp Gly Phe Asp Ile Trp Ser Ser Tyr Leu Ala Trp Gln Tyr 
            20                  25                  30          


Gly Ser Ser Pro Trp Met Phe Gly 
        35                  40  


<210>  1073
<211>  40
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Description of Artificial Sequence: Synthetic antibody

<400>  1073

Ile Gly Trp Ile Val Cys Ala Ala Pro Tyr Cys Ser Ser Gly Gly Ser 
1               5                   10                  15      


Cys Asn Asp Ala Phe Asp Ile Trp Ser Ser Tyr Leu Ala Trp Gln Tyr 
            20                  25                  30          


Gly Ser Ser Pro Trp Thr Phe Gly 
        35                  40  


